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ABSTRACT

Molecular Toxicology of Pyrrolizidine Alkaloids

by

Hea-Young Kim, Doctor of Philosophy
Utah State University, 1994

Major Professor: Dr. Roger A. Coulombe, Jr.
Program: Toxicology
Pyrrolizidine alkaloids are cytotoxic, carcinogenic, and anti-carcinogenic
in vivo and in vitro, and they produce many hazardous effects in humans and
animals. Pyrrolizidine alkaloids (PAs) also cross-link with DNA and/or protein.
However, whether such cross-linking is important to the toxic action of PAs is not
known. In addition, the exact mechanism underlying these DNA cross-links or
cytotoxicity is also not clear.
In three separate studies, I characterized the nature of PA-induced DNA
cross-links and the relationships between PA structures and cross-linking
potency. In the first study (Chapter II), I found that cross-linking potency of PA
congeners coincided with their abilities to cause cytopathologic effects.
Macrocyclic a ,p-unsaturated diesters PAs and their pyrrolic metabolites were the
most potent inhibitors of colony formation, and inducers of

cytopathologic

changes and megalocyte formation. The macrocyclic a ,p-saturated diester PA
and open diesters PAs slightly inhibited colony formation, and slightly changed
cell morphology. Retronecine and indicine N-oxide were completely inactive. In
the next study (Chapter Ill), I found that pyrrolic macrocyclic metabolites were

X

more potent DNA cross-linkers than their parent compounds as determined by
alkaline elution. The pyrroles of the macrocyclic diester PAs were potent DNADNA (inter- and/or intra) cross-linkers in Bst Ell-digested A.-phage DNA or
pBR322 plasmid DNA but dehydroretronecine and indicine N-oxide were not. I
also examined which DNA sequences were more susceptible to PA-induced
cross-links by using a series of restriction endonucleases to determine sequence
specificity. The most favorable cross-linking site for PAs appeared to be 5'd(GG) and 5'-d(GA) although other sites, 5'-d(CC) or 5'-d(CG), might be also
preferable cross-linking targets. In the next study (Chapter IV), I characterized
the nature of DNA-protein interactions induced by PAs, because I found in
previous studies that PA-induced cross-links are largely protein associated. In
PA or pyrrolic PA exposed cells, cross-linked proteins with molecular weights 40
- 60 kD were detected. Two-dimensional electrophoretic analysis revealed that
these proteins were probably acidic in nature. In an in vitro system utilizing
pBR322 or Bst Ell-digested A.-phage DNA. dehydrosenecionine induced DNAprotein cross-links with BSA, indicating that such interactions might be related to
amino acid composition of protein.
These results confirmed that PA-induced DNA cross-links (DNA-DNA,
DNA-protein cross-links) are influenced by three structural features : the C1 ,2
unsaturation of pyrrolizidine ring, a,p-unsaturation, and size of the macrocyclic
diester ring . The ability to form cross-links was closely related to the known toxic
potencies of these PAs. From this research, I also conclude that DNA crosslinking is the most critical event leading to PA-related diseases and that crosslinking is due to pyrrolic metabolites of PAs, not via a common metabolite as was
once thought.
(114 pages)

CHAPTER I
INTRODUCTION

Genotoxicity
DNA is a well-known intracellular target for genotoxic agents and some
anti-neoplastic drugs. Some of these agents induce cross-links in DNA which
may involve nuclear or non-nuclear proteins that have important roles in gene
regulation (Ban jar et a/., 1984; Lemaire eta/. , 1991 ). The interaction of DNA and
genotoxics can cause permanent or semi-permanent genomic changes. The
damaged DNA can be fully or partially repaired , although incorrectly repaired
DNA can induce genomic changes such as transition or transversion mutations.

Pyrrolizidine alkaloids
Pyrrolizidine alkaloids (PAs) are common natural plant alkaloids produced
by genera such as Senecio, Crotalaria, Heliotropium, and Symphytum (Bull et
a/., 1968; Smith and Culvenor, 1981 ). Pyrrolizidine alkaloids are cytotoxic,
carcinogenic, and anti-carcinogenic (Culvenor, 1968; Svoboda and Reddy,
1972; Newberne and Rogers, 1973; Schoental, 1975; Kuhara eta/., 1980; King
eta/. , 1987). Humans and other animals may be exposed to PAs in food and
feed . PAs or their toxic metabolites are secreted in the milk of lactating dairy
cattle and rats , and especially young animals are susceptible to PA toxicity
(Schoental and Magee, 1959; Dickinson eta/., 1976). Pyrrolizidine alkaloids are
toxic to most animal species. Horses, rats , and chickens are very susceptible,
while guinea pigs, sheep, and goats are resistant to PA toxicity (Schoental,
1963; Bull eta/., 1968; White eta/., 1973; Chesney and Allen, 1973; Shull eta/.,
1976; Goeger eta/., 1982; Peterson and Jago, 1984). These species differences
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of PA toxicity have been explained by the differences in the rate of metabolic
conversion of PAs to toxic metabolites {pyrroles) in the different animal species.
Pyrrolizidine alkaloid

poisoning

in

humans

is

endemic

in

some

geographical locations. In Afghan istan and West India, contamination of food
crops or the ingestion of herbs for the treatment of certain ailments is associated
with PA-related liver toxicities such as vena-occlusive disease (Tandon and
Tandon, 1975; Mohabbat eta/. , 1976; Tandon eta/., 1976a; Tandon eta/. ,
1976b; Tandon eta/., 1977; Tandon eta/., 1978). Pyrrolizidine alkaloid-related
hepatotoxicity may be a high risk factor for liver disease and a cause of mortality
in a segment of

the population, especially in developing countries where

ingestion of PAs in food or herbal medicines is common (Tandon et at., 1975;
Tandon eta/. , 1978; Stillman eta/., 1979; Huxtable, 1980).
Other PA-related effects include gastrointestinal lesions, pulmonary
hypertension, right ventricular hypertrophy, central nervous system disorders,
and vena-occlusive disease of the liver in both animals and humans (Bras and
Hill , 1956; Hill , 1960; Mclean, 1970; Bras, 1973). In animal experiments, a
single exposure to PAs progresses relentlessly to advanced chronic liver
disease and cirrhosis (Schoental and Magee, 1957, 1959; Nolan eta/. , 1966).
Pyrrolizidine alkaloids have also been reported to be synergistic with aflatoxins
in causing liver cirrhosis, hepatoma, or lung toxicity in primates and rats (Cook et
a/., 1950; Lin eta/., 1974; Culvenor, 1983).
The structures of some PAs and their metabolites are shown in Figure 1.
Pyrrolizidine alkaloids can be divided into four major structural groups: the
macrocyclic a,j3-unsaturated diesters (senecionine, seneciphylline, riddelliine,
retrorsine), the macrocyclic saturated diester (monocrotaline), open diesters
(heliosupine, latifoline), and necine base (retronecine). Mclean (1970) reported

MACROCYCLIC DIESTERS

SENECIPHYLLINE

RETRORSINE

RIDOELLIINE

SENECIONINE

OPEN DIESTERS

NECINE BASE

LATIFOLINE

HELIOSUPINE

RIETRONECINE

METABOLITES

:yj'
OEHYOROSENECIONINE

MONOCROTALINE

,~'
OEHYOROMONOCROTALINE

&SOH

OEHYORORETRONECINE

~"
!

INOICINE N-<>XIOE

Fig. 1-1 . Chemical stru::tures of pyrrolizidine alkaloids and their metabolites.
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that essential structures for the biological toxicities of PAs include a C1 ,2-double
bond in the pyrrolizidine ring and branched chain acids, and esterification with a
9-hydroxyl and 7-hydroxyl substituent.
Pyrrolizidine alkaloids are not biologically toxic per se but must first be
metabolized primarily by cytochrome P-450 mixed-function oxidase to either the
dehydro form (pyrrole), which is highly toxic, or the N-oxide form, which is less
toxic. The pyrrole is formed by allylic oxidation in pyrrolizidine ring followed by
cytochrome P-450 mixed-function oxidase mediated dehydration (Mattocks,
1968; Mattocks and White, 1971 ). The major metabolic routes of PAs are shown
in Figure 2. The major metabolic routes of the macrocyclic diester PAs in
animals are hydrolysis of the ester groups, N-oxidation, and dehydrogenation to
the pyrrole (Mattocks, 1986). The pyrrole alkylates cellular nucleophiles at either
or both ester linkages (Fig. 3). The relative animal toxicity of various PAs is
highly correlated to its metabolic fate (hydrolysis, dehydrogenation, N-oxidation)
which determines whether a larger or smaller proportion of the dose is converted
into toxic metabolites (Mattocks, 1970). For example, horses can convert PAs to
a larger proportion of pyrroles compared with sheep or goats, which produced a
larger proportion of N-oxides (White eta/., 1973; Goeger eta/. , 1982). The
hydrolysis rate of various PAs is inversely related to the presence of steric
hindrance around the ester groups (Mattocks, 1982; Bull eta/., 1968).

Interaction of PAs with DNA
Various PAs are mutagenic, carcinogenic, or anti-carcinogenic. In animals
and mammalian cells exposed to PAs, megalocyte formation is a common
cytopathologic sequelae which is postulated to be a result of the anti-mitotic
action of PAs (Bull and Dick, 1959; Tandon eta/., 1978; Mclean and Mattocks,

METABOLISM OF PYRROLIZJDINE ALKALOIDS

(OH

Rrv-.A(J::~·~•P450=arR-,-,_,?______. CO
HO'

~

PA pyrrole
(Dehydroalkaloid)

Dehydroretronecine

' ,,

'' . . .?
: ?

Pyrrolizidine alkaloid

'

+

Cytochrome P-450

Alkylation of cellular
macromolecules
N-o xi de

Retronecine

Fig. 1-2. Known and postulated metabolic pathways of pyrrolizidine alkaloids.

c.n

POSSIBLE MECHANISM OF CROSS-LINK FORMATION BY PAs
via 5N1 S olvolysis

For unsaturated esters, alkylation may also occur via Michael Ackflfion:
Nu:

Nu

~-X

H

Fig. 1-3. Possible reaction mechanisms between macrocyclic
unsaturated diester PAs with a nudeophilic atom (Nu).
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1980;

Kim

et

at.,

1993).

Lasiocarpine

and

its

pyrrolic

metabolite,

dehydroheliotridine, have been shown to specifically inhibit the late S or early
G2 phase of the cell cycle (Svoboda and Reddy, 1972; Samuel and Jago, 1975).
Results from our laboratory showed that the macrocyclic a,I'J-unsaturated diester
PAs (seneciphylline, riddelliine, retrorsine, and senecionine) induced the most
potent cross-linking activity, and also the most potent inhibition of colony
formation, suggesting that the DNA cross-links have a direct effect on mitosis
(Hincks eta!., 1991 ; Kim eta/., 1993).
Several

PAs have also been

reported to be genotoxic

in

the

Salmonella/mammalian microsomal (Ames) assay (Yamanaka et at. , 1979) or in
the unscheduled DNA synthesis assay (Green et at., 1981 ; Mirsalis et at., 1993).
Mori et at. (1985) found that 13 of 15 PAs were inducers of unscheduled DNA
synthesis in primary hepatocyte cultures.

Petry et at. (1984) reported that

monocrotaline and jacobine induced DNA-DNA cross-links but not single-strand
breaks in freshly isolated rat hepatocytes. Seneciphylline and senecionine
covalently bind to DNA and have a bifunctional alkylating capability in rat liver,
lung, and kidney in vivo (Candrian et at. , 1985).
Robertson (1982) showed that dehydromonocrotaline formed an adduct at
the N2 position of deoxyguanosine in synthetic oligonucleotides. Similar PAinduced cross-linking site specificity was also reported in synthetic DNA
duplexes in vitro (Woo et at., 1993). Their results strongly indicated N2 of
deoxyguanosine residues at the sequence 5'-d(CG) are the most common
binding site for pyrrole-derived bifunctional electrophiles. However, the exact
mechanisms of toxic, carcinogenic, or anti-carcinogenic actions of these
compounds are not yet clear.
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Pyrrolizidine alkaloid-induced cross-links
Our laboratory investigated how PA structural features influenced DNA
cross-links using the alkaline elution assay (Hincks eta/., 1991 ). With 8 PAs of
differing stereochemistry and functional groups, potent DNA-DNA and DNAprotein cross-linking abilities were found in cultured bovine kidney epithelial
cells with an external metabolizing system. The ranking of the PA-induced DNADNA cross-links and DNA-protein cross-links was the macrocyclic

a,/3-

unsaturated diesters (seneciphylline > riddelliine > retrorsine > senecionine),
open diester (heliosupine > latifoline), the macrocyclic saturated diester
(monocrotaline), and the necine base (retronecine) (Reed eta/., 1988; Hincks et
a/. , 1991 ). Two critical structural determinants for cross-linking activity were the
presence of a macrocyclic necic acid ester, and a,/3-unsaturation in the
macrocyclic diester.

Experimental methods for the investigation
of DNA cross-links
There are several strategies for studying of DNA-DNA and/or DNA-protein
cross-links. One of these is alkaline elution, which was developed by Kahn and
Grimek-Ewig (1973). Al kaline elution is based on the discrimination of various
lengths of [ 3H]-thymine labeled DNA by filter retention. Different filter systems
can be used for detection of different types of DNA damage.

Polycarbonate

filters are used for detecting single strand breaks, and polyvinylcarbonate filters
are used for detecting DNA-DNA and/or DNA-protein cross-links.
Recently, more specific molecular biological approaches have been
developed to characterize the sequence-specific interaction with DNA and
genotoxics. The most important of these is the DNA mobility shift or "band-shift"
assay (O'Connor and Fox, 1989; Banjar eta/., 1984; Oleinick eta/. , 1987), which
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is based on the retarded mobility of DNA-DNA or DNA-protein complexes
compared to untreated, non-cross-linked DNA during polyacrylamide or agarose
gel electrophoresis. This method is very useful to study DNA-DNA or DNAprotein cross-links, and DNA cross-linked sites and sequence specificity in
plasmid DNA using restriction endonucleases. Cellular DNA cross-linked
proteins can also be characterized by 2-D gel electrophoresis in which proteins
can be separated on the basis of isoelectric point in the first dimension, followed
by separation on the basis of molecular weight using SDS-PAGE (O'Farrell,
1975; Ames and Nikaido, 1976; O'Farrell eta/., 1977).
The purpose of this study was to determine the molecular mechanisms of
PA toxicity and examine which PA structures are critical for their molecular and
cytopathological effects using mammalian cells or target DNA systems. This
study will contribute to a better understanding of how PAs exert their acute and
chronic toxicity, carcinogenesis, and potential anti-carcinogenesis.
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CHAPTER II
STRUCTURAL INFLUENCES ON PYRROLIZIDINE ALKALOIDINDUCED CYTOPATHOLOGY

ABSTRACT
Pyrrolizidine alkaloids (PAs), which are common constituents of hundreds
of plant species around the world, have been reported to have cytotoxic,
carcinogenic, anti-neoplastic, or genotoxic activity in vivo and in vitro. The
mechanisms of these biological toxicities are not yet clear. The ability of eight
PA congeners to inhibit mitosis and induce megalocyte formation in cultured
bovine kidney epithelial (MDBK) cells was studied to examine possible structural
influences on these endpoints. Representatives of the three PA structural
groups, the macrocycles (seneciphylline, senecionine, riddelli ine, retrorsine,
monocrotaline), open diesters (heliosupine, latifoline), and a necine base
(retronecine), were co-cultured for 2 hr with NADPH generating system using the
rat liver S9. Macrocylic PAs with a,/3-unsaturation (seneciphylline, senecionine,
riddelliine , retrorsine) showed a dose-dependent inhibition of colony formation at
50, 100, and 300 I-'M and induction of megalocytosis at 500 I-'M. Colony growth
resumed 3 weeks after removal of PAs at 50 and 100 I-'M, and normal cellular
morphology returned

5 or 6 weeks after removal of PAs at 500 I-'M. The

saturated macrocyclic (monocrotaline) and open diesters (heliosupine and
latifoline) elicited only a slight inhibition of colony formation and had no effect on
cellular morphology at 500 I-'M. The necine base (retronecine) had no effect on
either colony formation or cell morphology. Pyrrolic PAs (dehydrosenecionine,
dehydromonocrotaline, dehydroretronecine) were more active in inhibition of
colony formation than their parent compounds and were potent inducers of
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abnormal

cellular

morphology

at

500

JLM.

An

N-oxide

metabolite,

indicine-N-oxide, was completely inactive. The results support previous studies
showing that there are structural influences on PA-induced cytopathological
effects.

INTRODUCTION
Pyrrolizidine alkaloids (PAs), which are common plant constituents, have
been reported to have potent anti-mitotic, hepatotoxic, and genotoxic activity in

vivo and in vitro (Petry et a/., 1984, 1986: Kuhara et a!., 1980; Mattocks, 1968;
Mori et a/., 1985; Schoental, 1975). Pyrrolizidine alkaloids induce severe acute
or chronic

liver and lung toxicities (Bull and Dick, 1959; Mclean, 1970).

Mattocks (1968) suggested that pyrroles are also potent anti-mitotic agents.
Pyrrolizidine alkaloids require metabolic activation to exert their biological
action . Activated PAs then interact with cellular constituents (Green eta/., 1981 ;
Segall et a/. , 1985; Griffin and Segall , 1986). Pyrrolizidine alkaloids are
metabolically converted by cytochrome P-450 mixed-function oxidase to two
major products: highly reactive and toxic pyrrole and the less toxic N-oxide
(Mattocks and White, 1971 ). Pyrrolizidine alkaloids are classified into four major
groups: macrocyclic diesters, open diesters, monoester, and necine base. The
biological toxicities of PAs are thought to be related to a,{3-unsaturation in the
structure of the necic acid esters and C1-C2 unsaturation of the necine base
(Bull eta!. , 1968; Mattocks, 1986; Mclean, 1970; Hincks eta!., 1991) and size of
the macrocyclic ring could also be important. We demonstrated (Hincks et a/.,
1991) that a group of 12-membered ring macrocyclic PAs bearing an a,{3unsaturated ester function in the macrocycle were more potent DNA crosslinkers than was monocrotaline, which contains an 11-membered macrocycle
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and lacks the a,J3-unsaturation. These PAs were also more potent than open
diesters and a necine base, retronecine.
Some PAs induce DNA-protein and/or DNA-DNA interstrand cross-links in
several in vivo or in vitro systems (Petry eta!., 1984, 1986; Candrian eta!.,
1985; Black and Jago, 1970; Hincks eta!., 1991 ; Niwa eta!., 1991; Reed eta/.,
1988). Pyrrolizidine alkaloids have been studied as chemotherapeutic agents
(Letendre eta/., 1981; King eta/. , 1987). For example, indicine N-oxide, derived
from Heliotropium indicum, has been found to have anti-tumor activity against
leukemia and solid tumors. Many PAs are also mutagenic in the Salmonella I
mammalian microsomal assay (Yamanaka eta/., 1979) and are genotoxic in the
unscheduled DNA synthesis assay (Green eta/., 1981; Mori eta/., 1985).
In PAs-exposed animals, enlarged cells or "megalocytes" are a common
pathologic sequela and are postulated to be a result of the anti-mitotic action of
PAs (Bull and Dick, 1959; Tandon eta!., 1978; Mclean and Mattocks, 1980).
Lasiocarpine (Svoboda and

Reddy,

1972)

and

its

pyrrolic

metabolite,

dehydroheliotridine, have been shown to specifically inhibit late S or early G2
phase of the cell cycle (Samuel and Jago, 1975).
We have recently identified structural features that appear to be important
in the DNA cross-linking capabilities of PAs (Hincks eta!., 1991 ). The purpose of
the present study was to determine whether there are similar structure-activity
relationships with respect to the cytotoxic and anti-proliferative action of a similar
group of PAs in vitro.

MATERIALS AND METHODS

Chemicals. Seneciphylline and senecionine were isolates from Senecio
vulgaris (common groundsel) and Senecio triangularis and furnished by Segall
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(1979 a; b). Retronecine was made by hydrolysis of riddelliine. Riddelliine was
an isolate from Senecio riddellii furnished by Molyneux et a/.

(1979).

Monocrotaline was purchased from Aldrich Chemical Company, Inc. (Milwaukee,
WI). Heliosupine was an isolate from Cynoglossum officinale (hounds-tongue)
furnished by Knight et a/. (1984). Latifoline was isolated and identified from

H. floribunda by Hagglund et a/. (1985).
Matthew

Suffness

(dehydrosenecionine,

of

the

National

lndicine N-oxide was provided by
Cancer

dehydromonocrotaline,

Institute.

Dehydro

dehydroretronecine)

PAs
were

prepared from their parent compounds (senecionine, monocrotaline, retronecine)
by the method of Mattocks eta/. (1989) and the purity of products was checked
by 1H NMR (Culvenor eta/., 1970). The chemical structures of PAs used in this
study are shown in Figure 11-1 .

Cell Culture and Treatment Conditions. The Madin Darby bovine kidney
(MDBK) epithelial cell line, strain CCL 22, was obtained from American Type
Culture Collection (Rockville, MD). The cells were grown in Eagle's minimum
essential medium with nonessential amino acids, L-glutamine (Gibco, Grand
Island, NY) and supplemented with 1 mM sodium pyruvate and 10% ironsupplemented calf serum (Hyclone laboratories, Logan, UT) at 37 °C in an
atmosphere of 97% air and 3% C02. Cells (passage 112-130) were seeded on
60-mm culture dishes or on 10-mm cover slips 22 hr prior to treatment. The
medium was replaced with fresh medium containing 50 - 500 I-'M of the PA with
an external metabolizing system which consisted of a NADPH-generating system
and rat liver S9 for the parent compounds or without external metabolizing
system for the metabolites and incubated at 37 °C for 2 hr. Alkaloids were
dissolved in dimethylsulfoxide (DMSO) and were added directly to the medium in
a volume that did not exceed 1% of the total volume. For the parent PAs, an
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external metabolizing system was used which consisted of a NADPH-generating
system and rat liver S9 as described by Madle et at. (1986). The S9 was
prepared from Aroclor 1254-induced male Sprague-Dawley rat's liver according
to Maron and Ames (1983). These fractions (protein content ca. 45 mg/ml) were
pooled, stored at -80 °C, and the same batch was used in all experiments. The
components of the S9 mix were 0.67 mM NADP, 0.83 mM glucose-6-phosphate,
1.33 mM MgCI2, 10 mM phosphate buffer, with 2% rat liver S9 (all as final
concentration in the culture medium).
Colony-Forming Efficiency and Microscopic Examination. Colony-forming
efficiency was determined by seeding 100 cells on 60-mm culture dishes 22 hr
prior to treatment with PAs.

The examination of megalocy1e formation and

morphological changes was determined by seeding 500 cells on 10-mm cover
slips 22 hr prior to treatment with PAs. After exposure to the PA for 2 hr, the
medium was replaced with fresh medium, which contained 40 pg/ml gentamicin
and 2.5 pg/ml amphotericin B, and cells were incubated for 6 weeks with medium
changed every third day. At selected intervals, cells were stained with 0.2%
methylene blue. Colony-forming efficiency was calculated by counting the
number of growing colonies in the treated group divided by the number of
colonies in the control group. All experiments were performed in duplicate and
repeated at least twice. A subset of cultures was established for morphological
and microscopic examination. For examination of megalocy1e formation and
morphological changes, the treated cells on the cover slips were fixed with
methanol, stained with 0.2% methylene blue, and examined by light microscopy.
Measurement of cell area was done with a Leitz microscope and computerassisted planimetry (JAVA, Jande! Scientific) at 160X. Four fields were randomly
selected and digitized for measurement, resulting in nine to twenty areas per the

21
selected time interval. Cell areas were measured by tracing the perimeters of
digitized images of whole cells followed by computer assisted calculation of cell
profile area.

Statistical Evaluations. Data were analyzed by one-way analysis of
variance, and where appropriate, a post hoc Fischer's LSD was conducted to
determine significance between groups. A level of p < 0.05 was chosen as
significant.

RESULTS
Pyrrolizidine alkaloids were not cytocidal to the MDBK cell cultures
because cells which were exposed to the highest pyrrolizidine alkaloid
concentration, 500 f'M, were viable as determined by trypan blue dye exclusion
(data not shown). The effect of various PAs on the colony-forming efficiency of
MDBK cells is shown in Figures 11-2 and 11-4. Of those examined, the macrocyclic
a,{J- unsaturated diesters (senecionine > seneciphylline > riddelliine > retrorsine)

were the most potent in inhibiting colony formation. Cells resumed normal growth
at 50 and 100 f'M , 2 or 3 weeks after removal of these PAs (senecionine,
seneciphylline, retrorsine, riddelliine) from culture, respectively. The highest
concentration of

these PAs (300 I-'M) caused a complete cessation of cell

growth for 6 weeks (Fig. 11-2). Cell growth was only slightly suppressed following
exposure to 500 I-'M of monocrotaline, heliosupine, or latifoline, and normal
growth resumed 2 weeks after removal of compound. The necine base
retronecine and indicine N-oxide were inactive in our cell system. The pyrrolic
metabolites,

dehydrosenecionine,

dehydromonocrotaline

and

dehydroretronecine, were more active in inhibiting colony formation than were
their corresponding parent compounds at the same concentration (Fig. 11-3, 11-4).

1o.ooo 1 : : S : - : N - - - - - - - - - - - - - - - - - - ,

22

1.000
0.1 00
0.010
0.001

l>.-l>.-l>.--1>.--l>.-----1>.

1.000E-4f-::R::R-'----''-----'----'-----'----'---I

.. .

1.000

>(.)

c

Q)

(.)

t;::
4-

w

~::::1~

0.100
0.010
0.001

l>.-l>.-l>.--1>.--l>.-----1>.

0"1
C

I.OOOE--4

E

1.000

1-=---''------'-----'o.----'---_._--....._--!

c>-

0
0

u

..

SP

!.J.--0-0 .............

·-·-·--·
r.r-;

L.

0
lL

··---~·~------··

0.100

•

•/"

0.010
0.001

1.000E-4

l>.-l>.-1>.--l>.--1>..--------1>.

t-....
R-D_...__

__._ ____.__ __.__ __.__ _....._--!

1.000
0.100

o-o SOuM
• - •100uM
l>.-i>.300uM
l>.-l>.-l>.--1>.--l>..--------A

0.010
0.001

1.000E-4 .___ _...__ __._ ____.__ __.__ __.__ _.....__J
0

2

J

5

Time (Weeks)
Fig. 11-2. Colony-forming efficiency in the macrocyclic a,(i-unsaturated diester
pyrrol izidine alkaloid-exposed cells. The results are presented as colonyforming efficiency where 1.0 represents no inhibition of colony formation . Data
are mean :t S.E. *Significant difference compared to the next highest
concentration (P < 0.05) at the same time point.

23
The morphologic appearance of cells treated with selected PAs is
presented in Figure 11-5. In cells exposed to 500 I-'M of the macrocyclic

a,/3-

unsaturated diester PAs, enlarged cellular morphology appeared 3 days after
removal of the PA (data not shown). In these cells, the cell area was increased
nearly 10-fold compared to control cells, and the cytoplasm of the megalocytes
was thin and stretched, and the nucleus appeared condensed (Fig. 11-5, 11-6). A
return to normal cellular morphology occurred after 4 weeks, but some
megalocytes persisted adjacent to normal cells up to 6 weeks after treatment. In
monocrotaline-treated cultures, a few megalocytes appeared, but the cell size
was only sightly increased and returned to normal within 2 weeks. Treatment
with heliosupine or latifoline caused slight megalocytosis and the size of the
cells returned to normal within 1 or 2 weeks after treatment. Treatment with
retronecine, or indicine N-oxide, did not cause any detectable cytopathological
changes. Compared to their parent compounds, the pyrrolic metabolites
dehydrosenecionine, dehydromonocrotaline, or dehydroretronecine were more
potent inhibitors of cell division (Fig. 11-4) and potent inducers of enlarged cells
although persistent megalocytosis was seen only in cultures exposed to
dehydromonocrotaline (Fig. 11-5, 11-6).

DISCUSSION
In a previous study from our laboratory, in which we examined the relative
DNA cross-linking abilities of pyrrolizidine alkaloids in the same cell system, we
found that PAs with the 11-membered macrocyclic a,{3-unsaturated ester group
of PAs (senecionine, seneciphylline, retrorsine, riddelliine) were the most potent
DNA cross-linkers (Hincks eta/., 1991 ). Several workers have also reported PAinduced DNA-protein and/or DNA-DNA cross-links, and PA-induced cytotoxicity
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Fig. 11-5. Phase-contrast photomicrographs of pyrrolizidine alkaloid-exposed
cells. Cells were exposed to 500 ILM of pyrrolizidine alkaloids, washed,
supplemented with fresh medium, and then cultured for 6 weeks. Cells were
exposed to (a) DMSO, (b) seneciphylline (SP), (c) retrorsine (RR), (d) riddelliine
(RD), (e) monocrotaline (MO), and (f) retronecine (RN). X400.

27
0.0 12
0-00t,jSQ

•-•SN

0.008

0.00-4-

0.000

o-oowso

r-..

N

E
E
..........

•-•we

.6-.0.HE

0.001

.o~.-.o~.LF

0-0RN

0

Q)
....

<{
Q)

u

0.000

o-oowso
e-eOHSN
.0.-.0.0HWO

0.008

0.004

2

4

Time (Weeks)
Fig. 11-6. Changes in cell area due to 500 !LM of pyrrolizidine alkaloid treatment.
The exposed cells were washed, supplemented with fresh medium, and cultured
for 6 weeks. The results are represented as cell areas (mm 2) by computerassisted calculation of cell profile area. *Significant difference (P < 0.05)
compared to control cells.

28

in vivo or in vitro systems (Black and Jago, 1970; Cardrian eta/., 1985; Griffin
and Segall, 1986; Hayes eta/., 1984, Lieber eta/., 1981 ; Moore eta/., 1989;
Petry eta/. , 1984, 1986; Pow is eta/. , 1979). The present data indicate that those
PAs, which were shown in previous studies to be potent DNA cross-linkers, are
also potent inducers of cytopathologic changes. Therefore, taken together with
previous work, the present data support the hypothesis that DNA cross-linking
activity is an important mechanism underlying PA bioactivity. Pyrrolizidine
alkaloids with the macrocyclic a,/3-unsaturated diester were by far the most
potent inducers of megalocytosis. Monocrotaline, the 12-membered macrocyclic
that does not have an a,/3-unsaturated ester group, showed only weak effects as
did the open diesters, heliosupine and latifoline. The necine base, retronecine,
which is not a potent DNA cross-linker, was also inactive in the present study as
was indicine N-oxide.
A key to the structure-activity relationships was the discovery that pyrrolic
PAs were more potent inhibitors of colony formation than their parent
compounds. Recently, Muller et a/. (1992) demonstrated the importance of
metabolic activation in the genotoxic activity of PAs. Particularly striking was the
fact that dehydromonocrotaline was highly active, while the parent compound,
which was activated by the external metabolizing system, had very low activity.
This suggests that the structural features which distinguish monocrotaline from
the other macrocyclic pyrrolizidine alkaloids are not important determinants of
biological activity itself, but are related to proper formation of the pyrrolic
metabolite. It is likely that the external

metabolizing system converts

monocrotaline more rapidly to the N-oxide than to the dehydro form, while the
opposite is the case for seneciphylline, retrorsine, riddelliine, and senecionine.
This is in line with the relative in vitro conversion by rat liver microsomal
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enzymes of monocrotaline to N-oxide or pyrrole compared to retrorsine and
senecionine (Mattocks and Bird, 1983). It is also possible that pyrrolic PAs are
hydrolyzed in our system to dehydroretronecine (Mattocks, 1986).
Those PAs which were most active in suppressing colony formation were
also most active in inducing megalocytosis. Pyrrolizidine alkaloid-induced mitotic
inhibition and formation of megalocytosis have been observed in vivo or in vitro
(Armstrong et a/. , 1972; Bull and Dick, 1959; Mattocks, 1986; Mattocks and
Legg, 1980; Schoental and Magee, 1957; 1959). A series of PAs were shown to
induce megalocytosis that persisted for up to 2 weeks in cultured liver cells and
that the time frame of cell enlargement coincided with that of mitotic inhibition
(Mattocks and Legg, 1980). Megalocytes with large and abnormally shaped
nuclei are frequently seen in livers of PA-exposed animals, which is consistent
with an inhibition at the late S or G2 phase of the cell cycle, a condition in which
synthesis occurs but not cell division (Samuel and Jago, 1975).
The mechanism of PA-induced megalocytosis has long been presumed to
involve mitotic inhibition. Jago (1969) suggested that megalocyte formation by
pyrrolizidine alkaloids is due to the persistent inhibition of mitosis (Jago, 1969;
Peterson, 1965). However, Armstrong et a/. (1972) found that lasiocarpine
induced a partial inhibition of DNA synthesis in cultured human fetal liver and
lung cells but the phenomenon was not directly related to mitotic inhibition.
Megalocytes induced by lasiocarpine were able to synthesize DNA but failed to
divide (Armstrong eta/., 1972).
In my system, cells exposed to the most potent PAs regenerated
approximately 6 weeks after treatment. Similarly, Schoental and Magee (1959)
reported that megalocytes that persisted for up to 2 years appeared in the livers
of PA-treated

rats. Megalocytosis

is

also

stimulated

either by partial
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hepatectomy, or following administration of thioacetamide or a necrogenic agent
such as dimethylnitrosamine (Downing and Peterson, 1968; Samuel and Jago,
1975; Mattocks, 1978). Culvenor eta/. (1976) reported that chronic treatment
with dehydromonocrotaline or dehydrosenecionine caused severe liver damage
in the rat, but there was no evidence of megalocy1e formation . My work
demonstrated that dehydromonocrotaline was a more potent inducer of
megalocy1es compared to monocrotaline that was activated with an external
metabolic system. However, dehydrosenecionine or dehydroretronecine were
only mildly active in inducing megalocytes. The explanation for this observation
is not clear, but it is possible that these reactive pyrrolic (dehydro) PAs bind with
nonnuclear constituents in the cell.
One PA examined here, indicine N-oxide, has been investigated for its
anti-tumor activity. Poster eta/. (1981) suggested that the anti-tumor activity of
indicine N-oxide is mediated via an anti-mitotic effect.

Letendre et a/. (1984)

also studied anti-tumor activity of indicine N-oxide in human acute leukemia and
reported myelo-suppression, hepatotoxicity, and anti-leukemic activity. My
results would indicate, at least in the cell system employed, that indicine N-oxide
is only modestly active in mitotic inhibition compared to other PAs. This would be
expected because indicine N-oxide must first be reduced to indicine before it
can be activated to the pyrrolic form of metabolite, which is responsible for
toxicity (Powis eta/., 1979). It is also possible that in this cell system, indicine
N-oxide does not enter the cell efficiently.
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CHAPTER Ill
CHARACTERIZATION OF DNA-DNA CROSS-LINKS
BY PYRROLIZIDINE ALKALOIDS

ABSTRACT
Pyrrolizidine alkaloids (PAs), which are common constituents of hundreds
of plant species around the world, are potent cross-linkers with DNA and/or
protein, and are also cytotoxic, carcinogenic, and anti-carcinogenic. In this
study, I investigated PA-induced DNA-DNA cross-links induced by PAs as
assessed by alkaline elution, electrophoretic band shifting, primer extension
using PCR, and differential restriction endonuclease digestion. At 300 and
500 f.!M, chemically activated PAs were potent DNA cross-linkers as assessed
by

alkaline

elution

with

a

potency

order

of

dehydrosenecionine

>

dehydromonocrotaline > dehydroseneciphylline > dehydroriddelliine. At 500 f.!M,
the DNA cross-linking activity of these metabolites exceeded that of their parent
compounds. Dehydroretronecine and indicine N-oxide did not induce detectable
DNA cross-links. Macrocyclic diester pyrroles also induced DNA-DNA crosslinks in Bst Ell-digested A.-phage DNA or Bam HI-digested pBR322 DNA in a
dose-dependent manner. Dehydrosenecionine and dehydromonocrotaline were
potent DNA-DNA interstrand cross-linkers but dehydroretronecine and indicine
N-oxide were not. Because dehydrosenecionine showed a preference for crosslinking at the Ava II, Fok I, or Taq I recognition site in pBR322 plasmid DNA, this
appeared to cross-link 5'-d(GG) or 5'-d(GA) sequences most frequently. The
macrocyclic

diester

pyrroles

such

as

dehydrosenecionine,

dehydroseneciphylline, dehydroriddelliine, and dehydromonocrotaline were the
most potent inducers of DNA-DNA cross-links, indicating that the cross-linking
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potency is inherent to the PA and that the cross-link formation does not proceed
through a common reactive intermediate.

INTRODUCTION
Pyrrolizidine alkaloids, which are found in a variety of plants including
Senecio, Crotalaria, and Heliotropium, are hepatotoxic, carcinogenic, mutagenic,

or anti-carcinogenic in vivo and in vitro (1-7). Humans and other animals are
susceptible to the toxic effects of PAs. Monocrotaline and jacobine induce DNAprotein and DNA interstrand cross-links but not DNA strand breaks in rat liver in
vivo (8, 9). Monocrotaline pyrrole induces DNA cross-links and inhibits cell

proliferation as well as morphologic, hemodynamic, and biochemical changes in
porcine pulmonary artery endothelial cells and rat lung (1 0, 11 ).
Pyrrolizidine alkaloids are metabolized by the cytochrome P-450 mixedfunction oxidase, resulting in a highly reactive and toxic pyrrole, and N-oxide,
which is less toxic (12-15). The PA-induced cytopathologic changes in vivo and
in vitro are due to the anti-mitotic effects of PAs (16-19), which inhibit the late S

or early G2 phase of the cell cycle (20, 21 ).
Dehydroretronecine reacts with purine and pyrimidine nucleotides. The N2 site of guanosine, the N-6 site of adenosine, and the 0-2 site of uridine and
deoxythymidine have been identified as targets (22-24). Dehydroretronecine
also cross-links pBR322 plasmid DNA and M13 viral DNA (25). Our laboratory
has shown that the macrocyclic a,(l-unsaturated diesters such as seneciphylline,
riddelliine, retrorsine, and senecionine are potent DNA cross-linkers in cultured
cells (26). These PAs were also potent inhibitors of colony formation and
inducers of cytopathologic changes, an indication that PA-induced DNA crosslinking activity is closely related to the inhibition of cell proliferation (19, 26).
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The purpose of this study was to characterize the nature of PA-induced
DNA cross-links and to determine if there are structural features that influence
DNA-DNA cross-link formation by PAs. Several representative parent PAs and
chemically activated pyrrolic PAs were used to determine possible structureactivity relationships.

MATERIALS AND METHODS
Materials
Chemicals. Senecionine, seneciphylline, retrorsine, and retronecine were

isolates from Senecio vulgaris and Senecio triangularis and furnished by Segall
(27, 28). Retronecine was made by hydrolysis of riddelliine. Riddelliine was an
isolate from Senecio riddellii furnished by Molyneux et al. (29) and monocrotaline
was purchased from Aldrich Chemical Company, Inc. (Milwaukee, WI). lndicine
N-oxide was provided by Matthew Suffness of the National Cancer Institute.
Pyrrolic

metabolites

dehydroriddelliine,

(dehydrosenecionine,

dehydromonocrotaline,

and

dehydroseneciphylline,
dehydroretronecine)

were

prepared from their parent compounds (senecionine, seneciphylline, riddelliine,
monocrotaline, and retronecine, respectively) by the method of Mattocks et a/.
(30), and purity was confirmed by 1H NMR (31). Pyrrolic metabolites were
dissolved in DMSO, and stored at -80 oc in capped amber vials filled with inert
gas. The chemical structures of PAs used in this study are shown in Figure 1.
Cis-dichlorodiammine platinum (II), mitomycin C, lysozyme (EC 3.2.1.17),
RNAse I (EC 3.1.2.75), proteinase K (EC 3.4.21 .14), ampicillin, tetracycline, and
ethidium bromide were obtained from Sigma Corporation (St. Louis, MO).
Eagle's Minimum Essential Medium was purchased from Sigma Corporation (St.
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Louis, MO) and iron supplemented calf serum was purchased from Hyclone
Laboratories, Inc. (Logan, UT). Methyi-[3 H]-thymidine was purchased from New
England Nuclear (Boston, MA). Bst Ell-digested A.-phage DNA was obtained
from New England BioLabs (Beverly, MA). Bacto-tryptone and bacto-yeast were
purchased from Difco (Detroit, Ml). Restriction endonucleases (Ava II, Eco Rll,
Fok I, Hint I, Mbo II, Taq I) were obtained from Promega Corporation (Madison,
WI). Taq polymerase, dATP, dTIP, dCTP and dGTP were obtained from Perkin
Elmer Cetus (Norwalk, CT). The primers used for the polymerase chain reaction
(PCR) were synthesized by the Biotechnology Center (Utah State University,
Logan, UT) via an oligonucleotide synthesizer (Applied Biosystem 380B DNA
synthesizer). Swinex filter holders and polyvinylchloride filters were obtained
from Millipore Corporation (San Francisco, CA).

Methods
Cell Culture and Treatment Conditions. Madin Darby bovine kidney
(MDBK) epithelial cells, strain CCL 22 (American Type Culture Collection,
Rockville, MD), were grown in Eagle's Minimum Essential Medium with
nonessential amino acids, L-glutamine, 1 mM sodium pyruvate, and 10% iron
supplemented calf serum at 37 °C in an atmosphere of 97% air and 3% C02.
Cells (passage 112-130) were seeded in 60-mm diameter culture dishes for
alkaline elution assay 24 hr prior to labeling with methyi-[ 3H]-thymidine. The
medium was then replaced with fresh medium, and treated with 300 or 500 11M of
PAs or pyrroles. Parent PAs were activated with an external metabolizing system
consisting of a NADPH-generating system and rat liver S9 as described by
Hincks et a/. (26). Pyrrolizidine alkaloids were added directly into the medium in
a volume that did not exceed 1% of total volume. Cell viability for all treatment
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groups exceeded 90% as determined by trypan blue dye exclusion (data not
shown).
Cellular DNA Cross-links by Alkaline Elution. The PA-treated cells were

washed and the medium was replaced with cold PBS (0.12 M NaCI, 4 mM KCI,
0.5 mM Na2HP0 4 , 0.1 mM KH2P0 4 , pH 7.4). The cells were then exposed to
1000 rad of y-irradiation at 0 °C using a 137Cs irradiator at a dose rate of 171
rad/min. The source was calibrated using the Fricke's ferrous sulfate dosimetry
method (32). Alkaline elution was conducted as described previously (26).
DNA-DNA Cross-/inks in A.-phage or pBR322 DNA. pBR322 plasmid DNA

was amplified in bacterial E. coli host (strain RR1) by overnight culture at 37 °C
in LB medium (1% bacto-tryptone, 0.5% bacto-yeast, and 0.89 M NaCI)
containing 15 llg/ml tetracycline and 50 1-1g/ml ampicillin. pBR322 plasmid DNA
was purified by the rapid alkaline method (33). Briefly, E. coli cells were
harvested by centrifugation at 5000 rpm for 10 min at 4 °C and the pellet was
lysed (25 mM NaCI, 10 mM EDTA, 15% sucrose, 2 mg/mllysozyme) for 20 min
at 0 °C. The lysate was incubated in 0.04 M NaOH with 0.04% SDS for 10 min,
and 0.075 M NaC2H302, pH 4.6 was added. The mixture was incubated for 20
min at 0 °C followed by centrifugation at 10,000 rpm for 15 min. RNAse (1
mg/ml) was added to the supernatant and the mixture was incubated for 20 min
at 37 °C . The sample was purified by phenol : chloroform (1 :1, v/v) extraction
and precipitated with ethanol. The DNA was dissolved in TE buffer (10 mM TrisHCI, 1 mM EDTA, pH 7.4), and repurified by adding 0.4 M NaCI and 6.5% (v/v)
polyethylene glycol for 1 hr at 0 °C, then centrifuged at 10,000 rpm for 10 min.
The plasmid was dissolved in TE buffer, pH 7.4 (10 mM Tris-HCI, 1 mM EDTA).
Bam HI-digested (1 U/1-1g DNA for 1 hr at 37 °C) pBR322 plasmid DNA or Bst

Ell-digested

A.-phage

DNA

(NEB)

was

treated

with

the

pyrrolic
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(dehydrosenecionine, dehydromonocrotaline, dehydroretronecine) or N-oxide
metabolite (indicine N-oxide) at DNA : PA (w:w) ratios of 1:0.5, 1.0, 2.0 for 2 hr
at 0 °C. A similar treatment ratio of cis-dichlorodiammine platinum(ll) or
mitomycin C was used as a positive cross-link control. After treatment, DNA
samples were precipitated with ethanol to remove excess cross-linkers. The
DNA-DNA cross-links were analyzed on 1% agarose gels stained with ethidium
bromide (34). The observed DNA band shifting was photographed by a Polaroid
MP-4 camera system using Polaroid Type 667 film.

Pyrrolizidine Alkaloid-induced Interruption of Primer Extension by PCR.
p8R322

plasmid

DNA

(dehydrosenecionine,

was

incubated

with

dehydroseneciphyll ine,

dehydroretronecine), indicine

pyrrolic

metabolites

dehydroriddelliine,

N-oxide or known DNA cross-linkers (cis-

dichlorodiammine platinum(ll), mitomycin C) for 2 hr at 0 °C and precipitated
with ethanol. The treatment ratios (DNA:PA, w:w) were 1 : 0.001 , 0.01 , 0.1, 0.25,
0.5, 1.0, and 2.0.
The treated pBR322 plasmid DNA was then used as a template for PCR.
Two primers, one complementary to the forward sequences from the Pst I
recognition site (5' GCT AGA GTA AGT AGT TCG CC 3'), and one
complementary to the reverse sequences from the Bam HI recognition site (5'
CAC GAT GCG TCC GGC GTA GA 3') were used. The reaction mixture (50 Ill),
which consisted of 4 ng of template DNA, 100 11M of each primer, 1 mM of each
dNTP (dATP, dCTP, dGTP, dTTP), Taq polymerase buffer, and 1.25 U of Taq
polymerase, was cycled for 1 min 10 sec at 55 °C , 1 min 20 sec at 70 °C, and 1
min 10 sec at 93 °C for 40 cycles in a DNA thermal cycler (EricComp, San
Diego, CA). The PCR products were separated on 1% agarose gels and then
stained with ethidium bromide.
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Pyrrolizidine Alkaloid-induced Interruption of Restriction Endonuclease
Digestion in pBR322 DNA. Circular or supercoiled double-stranded pBR322
plasmid DNA and Bst Ell-digested A.-phage DNA, which contained 13 fragments
of linear double-stranded DNA, were treated with PA for 2 hr at 0 °C, and
precipitated with ethanol. The DNA : PA ratios used were 1:0.5 and 1:1 (w:w).
The DNA was then digested by 3 U/Jlg DNA for 3 hr at 37 oc with Ava II, Fok I,
Hinf I or Mbo II or for 3 hr at 63 oc with Eco Rll or Taq I. The digests were
separated on 1% agarose gels stained with ethidium bromide (34 ).

The

recognition sites, size of fragments , number of cuts, and recogn ition sequences
of restriction enzymes are shown in Table 111-1. Bst Ell-digested A.-phage DNA
was treated with 1:1 ratio (w:w) of PA for 2 hr at 0 °C , precipitated with ethanol ,
and then digested by 3 U/Jlg DNA for 3 hr at 37 °C with Eco Rl.
Statistical Evaluation. Data were analyzed by one-way analysis of
variance, and where appropriate, a post-hoc Fisher's LSD was conducted to
determine significance between groups. The significance level was P < 0.05.

RESULTS
Cellular DNA Cross-links by Alkaline Elution
DNA cross-links induced by pyrrolic PAs and their parent PAs are shown
in Tables 111-2 and 111-3. The pyrrolic metabolites such as dehydrosenecionine,
dehydroseneciphylline, dehydroriddelliine, and dehydromonocrotaline potently
induced potent DNA cross-links at 300 JlM and 500 JlM. The pyrroles were
generally more potent DNA cross-linkers than their parent compounds. The
potency of DNA cross-l inking activities induced by dehydroretronecine and
indicine N-oxide were similar to their parent compounds, retronecine and
indicine, respectively. The potency of DNA cross-linking activity induced by
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Table 111-1. Recognition sites of restriction enzymes and fragment sizes of
pBR 322 plasmid.

ENZYME

RECOGITION
SITE

NO.
OF
CUTS

LOCATION OF
RECOGNITION SITES

FRAGMENT SIZE

(BP)

Ava II

5'GJ.GWCC3'

8

799 887 1136 1439
1481 1760 3504 3726

1744 1434 303 279
249 222 88 42

EcoRII

5'CC~WGG3'

6

130 1059 1442
2621 2634

2500

1857 1058 929 383
121 13

Fokl

5'GGATG(N)al3'

12

112 133 987
1681 1770 1848
2148 3346 3527

1032
2007
3814

1175 854
287 182
78
66

659
181
45

Hinfl

5' G~NTC3'

10

632 852 1006 1304
1525 2029 2373 2448
2844 3361

1632 517
344 298
154 75

504 396
221 220

Mboll

5'GAAGA(N) 813'

11

464 738 1009
2352 3123 3214
4047 4156 4352

1601
3969

792
494
109

751 592
253 196
70

Taq I

5'UCGA3'

7

24
339 652
1268 2573 4017

1127

1444 1305 475 368
315 313 141

W : A or T, and N : any base
Arrows represent the cutting site

755
271
78

649
141
44
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dehydromonocrotaline

was

similar

to

that

of

dehydroseneciphylline.

Monocrotaline was only as potent as retronecine. About half of the total crosslinks induced by pyrrolic PAs were proteinase K-resistant or DNA-DNA crosslinks (Table 111-3).

DNA-DNA Cross-links in A.-phage or
pBR322DNA

Band shifts induced by pyrrol ic PAs in Bst Ell-digested A.-phage DNA are
presented in Figures 111-2 and 111-3. In this experiment, DNA-DNA cross-links
caused an apparent increase in molecular weight of the target DNA evident as a
band shifting toward the top of the gel. In this system, dehydrosenecionine
induced the potent DNA-DNA cross-links, and did so in a dose-dependent
manner (Fig . 111-2). Dehydromonocrotaline also cross-linked, but it was less
potent than dehydrosenecionine which is evident as less band shifting toward
the top of the gel. Dehydroretronecine and indicine N-oxide did not cause band
shifting (Fig. 111-2). Cis-dichlorodiammine platinum (II), used as a positive control ,
induced band shifting at a potency similar to dehydromonocrotaline. Mitomycin
C, wh ich was also included as a standard, did not induce band shifting in this
system (Fig. 111-2). Compared to pyrrolic metabolites, parent PA itself did not
induce any DNA-DNA cross-linking at 500 J.!M (Fig. 111-3). Similarly, in Bam HIdigested pBR322 DNA, dehydrosenecionine and dehydroseneciphylline were
the most potent inducers of DNA-DNA cross-links (Fig. 111-4), especially at the
high dose ratio. Dehydromonocrotaline also induced potent DNA-DNA crosslinks, but the potency was less than macrocyclic a ,p-un saturated diester pyrroles
(dehydrosenecionine,

dehydroseneciphylline)

and

similar

potency

of

dehydroriddelliine at a 1:2 (DNA:PA, w:w) dose ratio. Dehydroretronecine or

46

Table 111-2. Pyrrolizidine alkaloid-induced total DNA cross-links1 .2.3.4

ALKALOIDS

METABOLITES

PARENT PAs

300 t' M

500 t' M

500 t' M

Dehydrosenecionine

1.46 :t 0.14•

2 .13 :t 0.24•

1.16;t0.18•

Dehydroseneciphylline

0.74 :t 0.17b,c 1.59 :t 0.18b

1.05 :t o.oga

Dehydroriddelliine

0.68 :t 0.08b

1.35 :t 0.24b

1.00 :t 0.07•

Dehydromonocrotaline

1.11

:t 0.18°

1.49 :t 0.22b

0.09 :t 0.05b

Dehydroretronecine

0.18 :t 0.01 d

0 .18 :t 0.02°

0.12 :t 0.03b

ND 4

0 .03 :t 0.01C

0.05 :t 0.01 b

lndicine N-oxide

1Treatments were for 2 hr at 37 °C.
2Data presented as mean total DNA cross-link indices :t S.E. from at least
three independent experiments.
3Cross-link indices with different superscripts are significantly different (P
< 0.05) by one-way ANOVA and F-test with in same concentration.
4ND, not detectable.
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Table 111-3. Pyrrolizidine alkaloid-induced proteinase K-resistant
(DNA-DNA) cross-links1

300 fLM2'3

%4

Dehydrosenecionine

0.67.:!: 0.09•

0.46.:!: 0.05

Dehydroseneciphylline

0.25.:!: 0.04b

0.49.:!: 0.09

Dehydroriddelliine

o.36.:!: o.o5•.b

0.55.:!: 0.12

Dehydromonocrotal ine

0.53.:!: 0.04•.b

0.51.:!:0.10

Dehydroretronecine

0.08.:!: 0.04<

0.46.:!: 0.26

ALKALOIDS

lndicine N-oxide

ND 5

ND

1As measured by alkaline elution.
2Data are presented as mean DNA proteinase K-resistant
cross-link indices.:!: S.E. which we define as DNA-DNA
cross-links. Data are from at least three independent experiments.
3Values with different superscripts are significantly different
(P< 0.05) by one-way ANOVA and F-test.
4The fraction of DNA-DNA cross-links .:!: S.E. of total DNA crosslinks.
SND, not detectable.
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DNA : Pyrrole Ratio

1:0. 5

1:1

1:2

1

2

3

4

5

6

7

Fig. 111-2. Band shifting analysis of PA-induced DNA-DNA cross-links in

Bst Ell-digested !..-phage DNA at three dose ratios (DNA:pyrrole, w:w)
visualized
in
ethidium
bromide-stained
1%
agarose
gels.
Dehydrosenecionine (lane 2) was the most potent inducer of DNA-DNA
cross-links. Lane 1, DMSO. Lane 2, dehydrosenecionine. Lane 3,
dehydromonocrotaline. Lane 4, dehydroretronecine. Lane 5, indicine Noxide. Lane 6, cis-dichlorodiammine platinum (II). Lane 7, mitomycin C.
M, molecular weight markers (,...)
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A. phage DNA

1 2 3 4

5 6 7 8 9 10 11 12

Fig. 111-3. Band shifting analysis of DNA cross-links in Bst Ell-digested A.phage DNA by PA alone or pyrroles at 500 1-!M in ethidium bromidestained 1% agarose gel. Monocrotaline (lane 8) alone did not induce any
DNA cross-links compare to dehydromonocrotaline (lane 9). Lane 1-2, A.phage Bst Ell-digested DNA alone. Lane 3, 4 mM of mitomycin C. Lane 4,
1 mM of cis-dichlorodiammine platinum (II). Lane 5, DMSO. Lane 6,
senecionine. Lane 7, dehydrosenecionine. Lane 8, monocrotaline. Lane
10,
retronecine.
Lane
11 ,
9,
dehydromonocrotaline.
Lane
dehydroretronecine. Lane 12, indicine N-oxide.
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indicine N-oxide did not induce DNA-DNA cross-links. Cis-dichlorodiammine
platinum (II) induced mild DNA cross-links, and mitomycin C did not induce DNADNA cross-links at the same dose.

Pyrrolizidine Alkaloid-induced Interruption
of Primer Extension by PCR

The ability of various pyrroles to cross-link a 1.129 kb region of p8R322
between the reverse direction of a Bam HI recognition site and the forward
direction of a Pst I recogn ition site is presented in Figure 111-5. In th is experiment,
the

macrocyclic diesters, dehydrosenecionine and

dehydromonocrotaline,

interrupted the primer extension by PCR as evidenced by the disappearance of
the 1.129 kb product. At the low dose ratios (1 :0.001, 0.01 , 0.1, 0.25; DNA:PA,
w:w), these pyrroles did not induce any DNA interstrand cross-links (data not
shown). However, at higher dose ratios

(1 :0.5,

1:1,

1:2)

(Fig.

111-5),

dehydrosenecionine induced the most potent DNA interstrand cross-links.
Dehydromonocrotaline also induced potent DNA interstrand cross-links but less
than that of dehydrosenecionine. Dehydroretronecine and indicine N-oxide had
no

effect

in

this

system.

Cis-dichlorodiammine

platinum(ll)

and

dehydrosenecionine induced DNA interstrand cross-links at the same potency.

Pyrrolizidine Alkaloid-induced Interruption
to Restriction Endonuclease Digestion
of pBR322 DNA

The

ability

of pyrrolic

PAs-induced

DNA-DNA

cross-links

within

recognition sites of various restriction endonucleases to inhibit the enzymatic
action was then studied to determine possible sequence preferences of pyrrolic
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1:2

1 :1

8Kb •
8Kb •
2Kb •

2Kb

•

Fig. 111-4. Band shifting analysis of PA-induced DNA-DNA cross-links in Bam HIdigested pBR322 plasmid DNA at the dose ratios 1:1, and 1:2 (DNA:pyrrole,
w:w) in ethidium bromide-stained 1% agarose gels. DNA cross-linking can be
seen as a shifting of DNA bands founds on top of the gel. Band shifting was
most evident in DNA treated with dehydrosenecionine (DHSN) and
dehydroseneciphylline (DHSP). DNA treated with cis-dichlorodiammine platinum
(II) (CIS) and mitomycin C (MMC) are included for comparison. Lane 1, pBR322
alone. Lane 2, Bam HI-digested pBR322.
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1 2 3

DMSO

INO

CIS

Fig. 111-5. Effect of pyrrole-induced cross-links on PCR amplification of pBR322
plasmid DNA. DNA products were separated on ethidium bromide-stained 1%
agarose. Primers used and amplification conditions are outlined in Materials and
Methods. Dehydrosenecionine was the most potent DNA interstrand cross-linker
as evident by disappearance of the amplified 1.129 kb segment. The dose ratios
of DNA : pyrrole were; 1:0.5 (lane 1), 1:1 (lane 2), and 1:2 (lane 3) (w:w).
(Arrow head) DMSO. (M) molecular weight markers.
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PA-induced DNA cross-links. The enzymatic action of Eco Rl was inhibited by
treatment of Bst Ell-digested A.-phage DNA with dehydrosenecionine as
evidenced by disappearance of the 0.9 kb DNA band. Dehydromonocrotaline,
dehydroretronecine, or indicine N-oxide did not inhibit the enzymatic action of
Eco Rl (Fig. 111-6).

In pBR322 plasmid DNA, dehydrosenecionine significantly inhibited the
endonuclease action of Ava II , Fok I, and Taq I at the high dose ratio
(DNA: cross-linker, 1:1; w:w}, moderately inhibited that of Eco Rll (ca. 0.4 kb) and
Mbo II (ca. 0.75, 0.6 kb}, and least inhibited with Hint I (ca. 0.2, 0.4, 0.75 kb)

(Fig. 111-7) observed as missing DNA bands. Cis-dichlorodiammine platinum (II)
induced cross-links within the recognition sites of all of these restriction
endonucleases. Dehydromonocrotaline induced few cross-linking sites (around
0.5 and 0.7 kb) with Mbo II. Dehydroretronecine, indicine N-oxide, or mitomycin
C did

not cross-link within

the

recognition

sites

of these

restriction

endonucleases, because the band patterns of these groups were the same as
that of control.

DISCUSSION
The purpose of this study was to characterize the pyrrolic PA-induced
DNA-DNA cross-links and to determine whether structural features on PAs can
influence the pyrrolic PA-induced DNA-DNA cross-linking activity. From previous
studies in our laboratory, macrocyclic a.,p-unsaturated diester PAs such as
seneciphylline, riddelliine , retrorsine, and senecionine were the most potent
DNA cross-linkers as determined by alkaline elution (26}, and had the most
potent anti-mitotic and cytopathologic effects (19) in cell culture relative to other
structural classes of PAs. In this study, I examined the types and degrees of PA-
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). phage DNA

EcoR I

Fig. 111-6. Evaluation of the ability of various pyrroles to cross-link DNA and their
cross-linked sites in Bst Ell-digested A.-phage DNA. For the detection of the
cross-linked site, Bst Ell-digested A.-phage DNA was cut with Eco Rl after
treatment with pyrroles at the dose ratio, 1:1 (DNA:pyrrole, w:w) and analyzed in
ethidium bromide-stained 1% agarose gel. Dehydrosenecionine (DHSN) and
dehydromonocrotaline (DHMO) induced mild DNA cross-linking at Eco Rl
recognition sites around 1 kb. DHRN, dehydroretronecine; INO, indicine Noxide; CIS, cis-dicholrodiammine platinum (II); MMC, mitomycin C; M, molecular
marker.
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1:0.5 (DNA : cross-l inker, w:w)

A

Ava 11

EcoR II

Mbo II

FOk I

Taq I

Fig. 111-7. Effect of pyrrole-induced DNA cross-links on digestion pattern of
pBR322 plasmid DNA by six restriction endonucleases. The DNA was treated
with pyrroles or known cross-linkers as positive controls at 1:0.5 (DNA : crosslinker, w:w; panel A, 8), and 1:1 (panel C, D) dose ratios using ethidium
bromide-stained 1 % agarose gel. Dehydrosenecionine (lane 3) was the most
potent DNA cross-linker and the cross-linked sites were at Ava II , Eco Rll , Fok I,
Mbo II , and Taq I recognition sites. Lane 1, pBR322 plasmid DNA alone. Lane
2, DMSO. Lane 3, dehydrosenecionine. Lane 4, dehydromonocrotaline. Lane 5,
dehydroretronecine. Lane 6, indicine N-oxide. Lane 7, cis-dichlorodiammine
platinum (II). Lane 8, mitomycin C.
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(continue Figure 111-7)

1:1 (DNA : cross-linker, w:w)
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I Kb ..
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induced

DNA

cross-links

by

alkaline

elution,

gel-shift

analysis,

PCR

amplification, and interruption of restriction endonuclease digestion.
My results showed that chemically activated pyrrolic PAs were more
potent inducers of DNA cross-links in cells than their parent compounds that had
been activated by an external metabolizing system. Parental PAs without an
external metabolizing system did not induce any DNA cross-links in Bst Elldigested f.-phage DNA, confirming the hypothesis that the pyrrolic metabolites
are the biologically active metabolites.
As in our previous studies (19, 26), I found that the macrocyclic a,!3unsaturated

diester

pyrroles

such

as

dehydrosenecionine,

dehydroseneciphylline, and dehydroriddelliine, and a a,[3-saturated diester
pyrrole dehydromonocrotaline were potent cellular DNA cross-linkers.
found

the

a,[3-unsaturated

macrocyclic

diester

pyrroles

also

such

as

dehydrosenecionine and dehydroseneciphylline were more potent DNA-DNA
cross-linkers

than

the

a,[3-saturated

macrocyclic

diester

pyrrole

dehydromonocrotaline in pBR322 plasmid DNA and Bst Ell-digested f.-phage
DNA. The necine base pyrrole dehydroretronecine or indicine N-oxide did not
induce DNA cross-links. Thus, structural features of pyrrolic PAs were reflected
in their differential DNA cross-linking activities.
My results suggested that the presence of both a,[3-unsaturation and a
macrocyclic ring such as in dehydrosenecionine and dehydroseneciphylline
might be the most important two structural features affecting pyrrole-induced
DNA cross-linking activity. Because these pyrroles were more potent than the
macrocyclic a,[3-saturated diester pyrrole dehydromonocrotaline, DNA crosslinks might be induced via the Michael addition reaction in addition to SN1
solvolysis, a common reaction to most of pyrrolic PAs with cellular nucleophiles

58
(35,

36).

In

addition,

the

o.,P-unsaturated

macrocyclic

pyrroles

(dehydrosenecionine, dehydroseneciphylline, and dehydroriddelliine) contain an
11-membered macrocycle ring , whereas dehydromonocrotaline has a 12membered macrocycle ring which may also influence the differential crosslinking potency.
The differences in the relative cellular DNA cross-linking activities of
parental PAs detected in this study suggested that PA structures influence their
metabolites wh ich are preferentially formed . For example, the macrocyclic o..Punsaturated diester PAs are more readily metabolized to pyrroles than are open
diesters, such as heliosupine and latifoline (37, 38). Retronecine, which is more
water soluble, forms relatively little pyrrole (37-39) . Thus, !he DNA cross-linking
activity may depend on the ratio of the biologically active form (pyrrole) to the
biologically less-active form such as necine or N-oxide (38, 40, 41 ). In this study,
macrocyclic diester pyrroles also induced more DNA cross-links than did the
necine base or N-oxides.
Our laboratory (19, 26) also found that those groups of PAs differed in
their DNA cross-linking potency and cytopathologic activity in cultured
mammalian cells (19, 26), further indicating that DNA cross-linking formation is
an important event leading to PA bioactivity. Those PAs that were the most
potent cross-linkers are also more acutely toxic to animals in vivo. For example,
senecionine was 3-6 times more acutely toxic than monocrotaline in the rats (40,
42). Another study indicated similar potency differences with respect to the
induction of unscheduled DNA repair in isolated hepatocytes (43).
Moreover, the metabolic pathways of various PAs also affect the
biological activities of PAs in different species (37-41, 44). Species of both farm
and laboratory animals differ in their susceptibilities to PAs (45). Pyrrolizidine
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alkaloids are toxic to most animal species such as chickens, horses, and rats ,
although some species such as guinea pigs, sheep and goats are relatively
resistant (46-49). The differences in susceptibility are largely due to the
metabolic pathway or conversion rate to nontoxic (necine, N-oxide) or toxic
metabolites (pyrroles) in animal tissues (48).
I further characterized the nature of pyrrolic PA-induced DNA-DNA crosslinks and structural influences by investigating pyrrolic PA-induced DNA-DNA
cross-linking activity (inter- and/or intrastrand cross-links), and cross-linked site
specificity using in vitro two target DNA systems: pBR322 plasmid DNA, wh ich
consists of supercoiled or circular double-stranded DNA, and Bst Ell-digested A.phage DNA, which consists of 13 fragments of double-stranded DNA In both
systems, the a ,f3-unsaturated macrocyclic diester pyrroles were the most potent
inducers of DNA-DNA cross-links. Dehydromonocrotaline formed more DNA
cross-links than did dehydroretronecine, and indicine N-oxide was not active.
Thus, it appeared the structural features that influenced DNA cross-linking
activity in cell culture hold true in target DNAs. The differences of cross-linking
potency between pBR322 plasmid DNA and Bst Ell-digested A.-phage DNA
suggested that the conformation of target DNA also could influence DNA-DNA
cross-linking activity induced by pyrrolic PAs.
Pyrroles that were potent inducers of DNA cross-links also effectively
inhibited PCR amplification of the 1.129 kb region of the pBR322 plasmid DNA
In this experiment, dehydrosenecionine was the most potent inducer of DNA
interstrand cross-links, somewhat more potent than was dehydromonocrotaline,
because the onset dose ratio of dehydromonocrotaline was higher (1 :1, w:w)
than dehydrosenecionine (1 :0.5, w:w). Dehydroretronecine or indicine N-oxide
had no effect. The potency of cis-dich lorodiammine platinum(ll) was similar to
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that of dehydrosenecionine. These results suggested that pyrrolic metabolites
were primarily responsible for inducing interstrand DNA cross-links and that a ,(lunsaturation in or size of the macrocyclic diester ring influenced the formation of
DNA interstrand cross-links by pyrrolic metabolites.
Previous work (22, 50, 51) has shown that pyrrolic metabolites alkylated
synthetic oligonucleotides containing a single 5'd(CG) sequence. I investigated
the sequence specificity of PA-induced DNA-DNA cross-links in pBR322 using
restriction endonuclease digestion. In this study, the recognition sites of Ava II
(5' -GG(~)CC) , Eco Rll (5'-CC(~)GG) , Fok I (5'-GGATG), Mbo II (5'-GAAGA),

and Taq I (5'-TCGA) were highly associated with cross-linking induced by
dehydrosenecionine, but the recognition site of Hint I (5'-GANTC) was not.
These data indicate that the pyrrolic PA-induced DNA-DNA cross-linking site
was preferentially related to 5'-d(GG), 5'-d(CC) or 5'-d(GA) sequences, although
other sequences might also be involved. These restriction endonucleases were
seldom inhibited by dehydromonocrotaline. As before, a ,(l-unsaturation in or size
of the macrocyclic diester ring appears to be an important structural feature in
pyrrole-induced DNA-DNA cross-links.
I included two bifunctional alkylating anti-cancer agents to compare the
relative

potency

of

pyrrolic

PAs.

The

known

DNA

cross-linker,

cis-

dichlorodiammine platinum (II), also induced potent DNA-DNA cross-links in this
study. This compound has been shown to produce potent DNA cross-links,
including interstrand DNA cross-links in short duplex DNA, 5'-d(CG)s, and the
preferred sequences might be 5'-d(CG) or 5'-d(GC) (24). However, mitomycin C,
whose DNA cross-link action is dependent upon reductive activation (52), did not
induce detectable DNA-DNA cross-links in this study. Other workers have found
that activated mitomycin C, which possesses structural similarities to pyrrolic
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PAs, appeared to preferentially cross-link with deoxyguanosine residues at the
sequence 5'-d(CG) in duplex DNA (51 , 53-54). The similarity in DNA crosslinking activity or structural features of pyrroles and those anti-cancer agents
suggests that the mechanism by which pyrrolic PA induces DNA cross-links
might be similar to that of those anti-cancer agents.
I also investigated DNA cross-linking sequence specificity using Eco Rl
cleavage of PA-treated Bst Ell-digested A.-phage DNA. Eco Rl (5'-GAATTC) can
cut in Bst Ell-digested A.-phage DNA, but at low rates . The DNA cross-l inking
potency differences between two target DNA systems, pBR322 plasmid DNA,
which consisted of circular or supercoiled double-stranded DNA, and Bst Elldigested A.-phage DNA, wh ich consisted of 13 fragments of linear doublestranded DNA, suggested that DNA cross-linking activity is influenced by
neighboring sequences and/or the native structure of the target DNA.
In summary, the a.,f3-unsaturation of the macrocyclic diester ring and
possibly its size, as well as the C1-C2 double bond, are structural features that
appear to affect the DNA cross-linking potency of PAs. Because the crosslinking potency among PAs roughly coincides with relative animal and cellular
toxicity, PA-induced DNA cross-linking activity does not involve a common PA
metabolite, dehydroretronecine. The significant portion of PA-induced crosslinks that are associated with protein may also contribute to the bioactivity of
these natural compounds. This will be the subject of future studies in our
laboratory.
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CHAPTER IV
CHARACTERIZATION OF DNA-PROTEIN CROSS-LINKS
BY PYRROLIZIDINE ALKALOIDS

ABSTRACT
Protein-associated DNA cross-links are implicated in the carcinogenic or
anti-carcinogenic activity of many compounds. In this study, I investigated the
DNA-protein cross-l inking activity of a group of natural pyrrolizidine alkaloids
(PAs) in vitro. The DNA cross-linked proteins induced by PAs were also isolated
and characterized in mammalian cells. At 300 J.!M, pyrrolic metabolites such as
dehydrosenecionine,

dehydromonocrotaline,

dehydroseneciphylline,

and

dehydroriddelliine induced DNA cross-links. Those that were protein-associated
accounted for approximately 50% of the total cellular DNA cross-links. The
simple necine base dehydroretronecine induced few DNA-protein cross-links
and none were detected with indicine N-oxide. Macrocyclic PAs (senecionine,
seneciphylline, riddelliine , retrorsine , monocrotaline) induced

DNA-protein

cross-links in cultured cells. The major proteins cross-linked to DNA from either
PA-exposed cells or pyrrolic PA-exposed nuclei were in the molecular weight 40
- 60 kD range as determined by SDS-PAGE. Two-dimensional electrophoresis
revealed that the proteins involved in cross-links were primarily acidic in nature.
The macrocyclic pyrrole, dehydrosenecionine induced DNA cross-links in Bst
Ell-digested !..-phage DNA and pBR322 plasmid DNA with BSA as a protein
target. The cross-linked proteins to DNA in patterns were similar to that induced
by the anti-cancer agents, mitomycin C and cis-dichlorodiammine platinum(ll).
My data indicated that pyrrolic PAs with a macrocyclic diester such as
dehydrosenecionine,

dehydroseneciphylline,

dehydroriddelliine,

and
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dehydromonocrotaline were more potent cross-linkers than the simple necine
base. Furthermore, because of the potency differences between pyrrolic
metabolites, it is likely that DNA-protein cross-links do not occur via a common
metabolite as previously proposed. Cross-linking potency of the PAs examined
here coincides with known potency differences in animal toxicity and led me to
conclude that DNA-protein cross-li nking activity is probably involved in PArelated diseases.

INTRODUCTION
Pyrrolizidine alkaloids are natural toxins found in a wide variety of plant
species that pose significant health hazards to humans and other animals (1 ).
Many PAs are toxic and carcinogenic (2-8) and are associated with chronic liver
disease in humans and other animals (5, 9, 10). Dehydromonocrotaline and
jacobine induced DNA-protein and DNA interstrand cross-links in rat liver in vivo
(4, 5). Dehydromonocrotaline also induced DNA cross-links and caused antimitotic and cytopathologic effects in porcine pulmonary artery endothelial cells
and rat lung (11 -13). These DNA-protein cross-links are toxicologica lly important
lesions and can also be induced by a variety of agents such as y- and UVirradiation, chromium, and formaldehyde (14-19). The proposed action of antitumor agents such as nitrogen mustard, cisplatin, mitomycin C, or nitrosourea is
thought to be related to their abilities to induce DNA cross-links (18, 20-23). In
our laboratory, we demonstrated that cytopathologic changes and anti -mitotic
activity of PAs were related to their ability to induce DNA-DNA or DNA-protein
cross-links (24, 25).
Pyrrolizidine alkaloids are bioactivated by the cytochrome P-450 mixedfunction oxidase to form the bifunctional electrophilic pyrroles, which then
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alkylate cellular macromolecules such as DNA and protein (4, 5, 26, 27). The
toxic effects of pyrrolic metabolites are apparently related to their DNA crosslinking activity.
A previous study from our laboratory has shown that PAs cross-link DNA
with protein (24). In this chapter, I investigated the characteristics of PA-induced
DNA-protein cross-links. I also characterized the nuclear proteins involved in
these cross-links in a cellular system, and examined the ability of a variety of
pyrrolic PAs to induce DNA-protein cross-links in target DNA.

MATERIALS AND METHODS
Materials
Senecionine and seneciphylline were isolates from Senecio vulgaris and
Senecio triangularis, and furnished by Segall (28, 29). Riddelliine was an isolate
from Senecio riddellii, and furnished by Molyneux eta/. (30). Monocrotaline was
purchased from Aldrich Chemical Company, Inc. (Milwaukee, WI). Retronecine
was prepared by hydrolysis of riddelliine isolated from Senecio riddellii, and
indicine N-oxide was provided by Matthew Suffness of the National Cancer
Institute. Pyrrolic PA metabolites (dehydrosenecionine, dehydroseneciphylline,
dehydroriddelliine, dehydromonocrotaline, dehydroretronecine) were prepared
from

their

parent

compounds

(senecionine,

seneciphylline,

riddelliine,

monocrotaline, retronecine, respectively) by the method of Mattocks eta/. (31)
in our laboratory. The purity of these metabolites was checked and confirmed by
1H NMR (32). The chemical structures of PAs and other compounds used in this
study are shown in Figure IV-1 .
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Eagle's Minimum Essential Medium was obtained from Gibco BRL (Grand
Island, NY) and iron-supplemented calf serum was obtained from Hyclone
Laboratories (Logan, UT). Methyi-[3H]-thymidine was obtained from New
England Nuclear (Boston, MA). Cis-dichlorodiammine platinum(ll), mitomycin C,
actin, myosin, lysozyme (EC 3.2.1 .17), RNAse I (EC 3.1 .2. 75), proteinase K (EC
3.4.21 .14), ampici llin, tetracycline, and ethidium bromide were obtained from
Sigma Corporation (St. Louis, MO). Ampholine was purchased from Pharmacia
LKB Biotechnology (Piscataway, NJ), and bacto-tryptone and bacto-yeast were
obtained from Difco (Detroit, Ml). Histone was purchased from Boehringer
Mannheim Corporation (Indianapolis, IN). DNAse I and Bst Ell digested A.-phage
DNA were obtained from New England Biolabs (Beverly, MA). Bovine serum
albumin (BSA) was obtained from Promega Corporation (Madison, WI). Swinex
filter holders and polyvinylchloride filters were purchased from Millipore
Corporation (San Francisco, CA).

Methods
Cell Culture and Treatment Conditions. The Madin Darby bovine kidney
(MDBK) epithelial cells, strain CCL 22, obtained from American Type Culture
Collection (Rockville, MD), were grown in Eagle's Minimum Essential Medium
containing nonessential amino acids, L-glutamine, 1 mM sodium pyruvate and
10% iron-supplemented calf serum. Cells were cultured at 37 °C in an
atmosphere of 97% air and 3% C02. Cells (passage 112-130) were seeded in
60-mm diameter culture dishes 22 hr prior to labeling with methyi-[ 3H]-thymidine
for alkaline elution assay or in 100-mm diameter culture dishes for the
characterization of cellular DNA cross-linked proteins where parent PAs were
used, and an external metabolizing system, which consisted of a NADPH-

72
generating system and rat liver S9 fraction, was added (24). Pyrrolizidine
alkaloids and their metabolites were dissolved in DMSO and added directly to
the medium in a volume that did not exceed 1% of the total volume. Cell viability
for all treatment groups exceeded 90% as determined by trypan blue dye
exclusion (data not shown).
Quantitation of Cellular DNA Cross-links by Alkaline Elution. Cells seeded
in 60-mm diameter culture dishes were labeled with 0.1 11Ci/ml of methyi-[3H]thymidine (2 Ci/mmol) for 22 hr. The medium was changed before cells were
treated with PAs or their metabolites. The cells were washed and replaced with
cold PBS (0.12 M NaCI, 4 mM KCI, 0.5 mM Na2HP04, 0.1 mM KH2P04, pH
7.4) after 2 hr incubation with PAs or metabolites. Cells were then exposed to
1000 rad of y-irradiation at 0 °C using 137Cs irradiator at the dose rate of 171
rad/min. They-irradiation source was calibrated using the Fricke's ferrous sulfate
dosimetry method (33). Alkaline elution was performed as described in a
previous paper (24).
Isolation and Characterization of DNA Cross-linked Proteins from Cells
and Nuclei. Cells (80- 85% confluence) were treated with 1 mM of each PA for 4
hr at 37 oc . Nuclei, wh ich were isolated from cultured MDBK cells by lysing with
0.3% Triton X-1 00 in 150 mM NaCI and 1 mM EDTA buffer and centrifugation at
3000 rpm, were treated with 1 mM of pyrrolic PA for 4 hr at 37 oc. Cells or nuclei
were also treated with 6 mM of cis-dichlorodiammine platinum(ll) or 400 11M of
mitomycin C for 6 hr at 37 oc. The treated cells and nuclei were washed twice
with ice-cold PBS containing 0.1 mM of phenylmethylsulfonyl fluoride. DNA
cross-linked proteins were then isolated using a modification of the method of
Banjar et a/. (34). Briefly, treated cells or nuclei were lysed in 2% (w/v) SDS,
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50 mM Tris-HCI , 0.1 mM phenylmethylsulfonyl fluoride, pH 8.0, and stirred for 7
hr on a rotatory stirrer. The cross-linked proteins were separated from noncross-linked proteins by ultracentrifugation (1 00,000 x g) for 17 hr at 19 °C. The
DNA cross-linked proteins were then resuspended using Down's homogenizer in
2 mM Tris-HCI, pH 7.0 including 0.1 mM phenlymethylsulfonyl fluoride , then
sonicated 4 times for 20 sec at 0 °C (35). The sonicated sample was digested
with DNAse I (40 llg/mg DNA) for 1 hr at 37 °C , dialyzed overnight against
double distilled water, and freeze dried.
Proteins, which were cross-linked to 40 llg of DNA isolated from the
treated whole cells, were analyzed by SDS-polyacrylamide gel electrophoresis
(SDS-PAGE) as described by Laemmli (36). The running· gel consisted of 15%
(samples from cells) or 11% (samples from nuclei) acrylamide, 0.4% N,N'methylenebisacrylamide in 0.375 M Tris-HCI, 0.1% (w/v) SDS, pH 8.8. The
stacking gel consisted of 4.5% acrylamide, 0.12 % N,N'-methylenebisacrylamide
in 0.125 M Tris-HCI, 0.1% (w/v) SDS, pH 6.8. The freeze-dried samples were
dissolved in loading buffer (1% (w/v] SDS, 5% [v/v]2-mercaptoethanol, 10% [v/v]
glycerol, 6.25 mM Tris-HCI, 0.05% [w/v] bromphenol blue, pH 6.8), and were
electrophoresed at 50 V in reservoir buffer (0.192 M glycine, 25 mM Tris, 0.1 %
[w/v] SDS , pH 8.3). The SDS-polyacrylamide gel was stained using a modified
silver staining method (37, 38).
The proteins, which were cross-linked to 100 llg of DNA isolated from the
treated nuclei, were also separated by isoelectric focusing followed by SDSpolyacrylamide gel (2-D) electrophoresis (39-41 ). The isoelectric focusing gel
consisted of 9.5 M urea, 0.2% N,N'-methylenebisacrylamide, 3.4% acrylamide,
2% NP-40, 2% ampholines (pH 5.0- 8.0, and 3.0- 10.0). The protein sample
was dissolved in lysis buffer (9.5 M urea, 2% NP-40, 2% ampholines, 5%

13-
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mercaptoethanol). The gel ran for 14 hr at 400 V followed by 1 hr at 800 V, then
equilibrated with sample buffer (62.5 mM Tris,

10% glycerol , 5%

13-

mercaptoethanol, 2.3% SDS) for 45 - 60 min at room temperature.
The isoelectric focusing gel was then loaded on top of a SDSpolyacrylamide slab gel and connected to the stacking gel using 0.4% agarose.
The

separating

gel

consisted

of

12.15%

acrylamide,

0.34%

N,N'-

methylenebisacrylamide, 0.375 M Tris, and 0.1% SDS, pH 8.8, and the stacking
gel consisted of 4.8% acrylamide, 0.13% N,N'-methylbisacrylamide, 0.12 M Tris,
and 0.1% SDS, pH 6.7. The gel was run at 40 Vovernight and then stained with
silver nitrate (37, 38).
DNA-protein Cross-links in pBR322 Plasmid DNA or A.-phage DNA.
pBR322 plasmid DNA was amplified in bacterial E.coli host (strain RRI) by
overnight culture at 37 oc in LB medium (1% bacto-tryptone, 0.5% bacto-yeast,
0.89 M NaCI) containing 15 J.!glml tetracycline and 50 11glml ampicillin. pBR322
plasmid DNA was purified by the rapid alkaline method (42). Briefly, E.coli cells
were harvested by centrifugation at 5000 rpm for 10 min at 4 °C and the
bacterial cell pellet was lysed (25 mM NaCI , 10 mM EDTA, 15 % sucrose, 2
mglml

lysozyme) for 20 min at 4 °C. The lysate was incubated with 0.04 M

NaOH and 0.04% SDS for 10 min and was then mixed with 0.075 M NaC2H302,
pH 4.6. The mixture was incubated for 20 min at 0 °C followed by centrifugation
at 10,000 rpm for 15 min. RNAse (1 mglml) was added to the supernatant which
was incubated for 20 min at 37 °C. The sample was purified by phenol :
chloroform (1 :1, vlv) extraction, and then precipitated with ethanol. The DNA was
dissolved in TE buffer (10 mM Tris-HCI , 1 mM EDTA, pH 7.4) and incubated with
0.4 M NaCI and 6.5% polyethylene glycol for 1 hr at 0 °C. This solution was
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centrifuged at 10,000 rpm for 10 min. Plasmid DNA was dissolved in TE buffer
pH 7 .4 (10 mM Tris-HCI, 1 mM EDTA).
In this experiment, two target DNA systems were used: pBR322, which
consists of supercoiled or circular double-stranded DNA, and Bst Ell-digested A.phage DNA, which consists of 13 fragments of linear double-stranded DNA The
DNA-protein cross-links were investigated in pBR322 plasmid DNA treated with
dehydrosenecionine or dehydromonocrotaline, and co-incubated with BSA at the
DNA : pyrrole : protein ratios of 1:1:0.5, 1:1:1 or 1:1:2 (w:w:w). The DNA-protein
cross-links were also characterized in Bst Ell-digested A.-phage DNA The DNA
was treated with dehydrosenecionine and simultaneously co-incubated with
actin, BSA, histone, or myosin in TE buffer (10 mM Tris-HCI, 1 mM EDTA, pH
7.4) at DNA : pyrrole : protein ratios of 1:1:0.5, 1:1:1 , or 1:1:2 (w:w:w) for 2 hr at
0 °C . Dimethylsulfoxide (DMSO) was used as control. The cross-linked DNAprotein was separated on ethidium bromide stained 1% agarose gels (43). The
ethidium bromide-stained DNA was photographed by a Polaroid MP-4 camera
system and Polaroid Type 667 film .
Statistical Evaluations. Data were analyzed by one-way analysis of
variance, and where appropriate, a post hoc Fisher's LSD was used to
determine significance (P < 0.05) among groups.

RESULTS
Quantitation of DNA Cross-links

by Alkaline Elution
The extent of cellular DNA cross-links by various PAs and their pyrrole or
N-oxide metabolites as determined by alkaline elution is shown in Table IV-1 .
None of the compounds examined induced single-strand breaks (data not
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shown). The pyrrolic metabolites were potent inducers of DNA-protein crosslinks. The order of potency was dehydrosenecionine > dehydromonocrotaline >
dehydroriddelliine > dehydroretronecine > indicine N-oxide. About 50% of DNA
cross-links induced by pyrroles involved proteins, as determined by proteinase K
treatment (Table IV-1 ).

Characterization of DNA Cross-linked
Proteins from Cells and Nuclei

Because the alkaline elution experiments showed that a significant
proportion at PA-induced cross-links was protein associated, I then examined
the type of proteins involved in the cross-links. All of the parent PAs examined,
except retronecine, induced DNA-protein cross-links in cultures of whole cells
(Fig. IV-2A). The proteins most often cross-linked with cellular DNA following
treatment with PAs had molecular weights in the range of ca. 40 - 60 kD.
Senecionine, retrorsine , and heliosupine also induced DNA-protein cross-links
(data not shown). A similar pattern of DNA cross-linked proteins was seen in
isolated nuclei treated with the pyrrolic metabolites such as dehydrosenecionine,
dehydroseneciphylline, dehydroriddelliine, and dehydromonocrotaline (Fig . IV28).

Dehydroretronecine

did

not

induce

DNA-protein

cross-links.

Cis-

dichlorodiammine platinum(ll) (cells and nuclei) and mitomycin C (cells) also
induced similar patterns of DNA cross-linked proteins, which had molecular
weights in the range of ca. 40 - 70 kD with cis-dichlorodiammine platinum( II) and
ca. 35- 100 kD with mitomycin C.
As evaluated by 2-D gel electrophoresis, DNA cross-linked proteins
induced

by

macrocyclic

dehydroseneciphylline,

a.,~-unsaturated

dehydrosenecionine,

diester
and

pyrroles

such

dehydroriddelliine

as
were
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Table IV-1 . Pyrrolizidine alkaloid-induced cellular DNA cross-links

TOTAL DNA
CROSSLINKS 4

DNA-DNA
CROSSLINKS 4

Dehydrosenecionine

1.46 ± 0.13•

0.67 ± 0.09•

0.78±_0.11•

0.54 ± 0.08

Dehydroseneciphylline

0.74±0.16b

0.25.!. 0.04b

0.49.!. 0.20•

0.51_±0.15

Dehydroriddelliine

0.69 ± 0.10b

0.36 ± o.o5•.b

0.31 ± 0.10b

0.50 ± 0.13

Dehydromonocrotaline

1.11_±0.17<

0.53.!. 0.04•·b

0.58.!. 0.19•·b

0.51.!. 0.17

Dehydroretronecine

0.18 ± 0.01d

0.08.!. 0.04<

0.09.!. 0.04<

0.52 ± 0.26

ALKALOIDS

lndicine N-oxide

ND 5

ND

DNA-PROTEIN
CROSSLINKS4

1,2,3

ND

fS

ND

1rreatments were 300 11M for 2 hr at 37 oc.
2Values with different superscripts are significantly different (P < 0.05) by oneway ANOVA and F-Iest within same type of cross-links.
3As measured by alkaline elution.
4Data presented as mean DNA cross-link indices ± S.E. from at least three
independent experiments.
5ND, not detectable.
6rhe DNA-protein cross-linking fraction of total DNA cross-links± S.E.
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Fig. IV-2. Electrophoretic separation of DNA-protein cross-links from whole cells
(A) or nuclei (B) treated with PAs or pyrrolic PAs. DNA cross-linked proteins
were separated on 15% (A) or 11% (B) SDS-PAGE staining with siver nitrate. All
samples were standardized to 40 1-1g DNA. The most prominent cross-linked
proteins were around the molecular weight range 40 - 60 kD. Residual DNAse I
appears around 32 kD. These data indicate that the macrocyclic diester PAs
induced the most potent DNA-protein cross-links.
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Fig. IV-3. Two-dimensional (2-D) electrophoretic separation of PA-induced DNA
cross-linked proteins from treated nuclei. The DNA cross-linked proteins were
separated by isoelectric focusing and then separated by 12.5% SDS-PAGE. The
proteins which were cross-linked with 100 Jlg of DNA were used for isoelectric
focusing . The most prominent proteins are at the acidic side of 2-D gel. Panel A,
DMSO. Panel B, dehydroseneciphylline. Panel C, dehydrosenecionine. Panel
D, dehydroriddelliine. Panel E, dehydroretronecine. Panel F, cisdichlorodiammine platinum (II).
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primarily in the acidic portion of the gels (Fig. IV-3A-C). The staining pattern of
the DNA cross-linked proteins from dehydroretronecine-treated nuclei (Fig. IV3E) was identical to that of the control. The pattern of DNA-protein cross-links
induced by cis-dichlorodiammine platinum (II) was similar to that induced by the
macrocyclic o.,f3-unsaturated diester pyrroles (Fig. IV-3F).

DNA-protein Cross-links in p8R322 Plasmid
or ).-phage DNA
It was of interest to determine whether pyrrolic PA-treated DNA can crosslink with added protein such as BSA, histone, actin, or myosin in vitro. As can be
seen in Figure IV-4, dehydrosenecionine and dehydromonocrotaline induced
slight cross-links between pBR322 plasmid DNA and BSA as evidenced by the
slight electrophoretic mobility change of DNA bands compared to that of the
control. Cis-dichlorodiammine platinum(ll) also induced DNA-BSA cross-links in
pBR322. Dehycrosenecionine-induced DNA-protein cross-linking was also
investigated in Bst Ell-digested A.-phage DNA (Fig. IV-5). Dehydrosenecionine
induced cross-links between A.-phage DNA and BSA, but did not cross-link with
actin or myosin at the high dose ratio. Histone was completely cross-linked to
DNA even at the lowest dose ratio (1 :1:0.5; DNA : dehydehydrosenecionine :
histone, w:w:w), wh ich was evidenced by a shifting of the DNA band to the top of
the gel.

DISCUSSION
We have previously shown that PAs are potent bifunctional alkylators of
cellular DNA, and that a significant portion of these lesions was protein
associated (24). We also found that PA structure influenced the formation of
PA-induced DNA-DNA cross-links. Therefore, in this study, I characterized PA-
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8Kb.,.

2Kb ..

DHSH

DHIIO

CIS

Fig. IV-4. Effect of BSA on the electrophoretic mobility of pyrrolic PAs crosslinked in pBR322 plasmid DNA. The cross-linked samples were separated by
ethidium bromide-stained 1% agarose gel electrophoresis. Dehydrosenecionine
induced DNA-protein cross-links dose dependently as appearing by the
electrophoretic mobility changing of samples compared to DMSO. The dose
ratios (DNA : cross-linker : BSA, w:w:w) were 1:1 :0.5 (lane 1), 1:1:1 (lane 2),
1:1 :2 (lane 3).
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Fig. JV-5. Effect of addition of various proteins on dehydrosenecionine-induced
DNA cross-links in Bst Ell-digested !..-phage DNA at treatment ratios of 1:1:0
(Lane 1), 1:1:0.5 (lane 2), 1:1:1 (lane 3), 1:1:2 (Jane 4) (DNA :
dehydrosenecionine : protein, w:w:w) on ethidium bromide-stained 1% agarose
gel. Lane a, !..-phage BstE ll•digested DNA alone; Jane b, DMSO; lane c,
dehydrosenecionine; lane d, cis-dichlorodiammine platinum (II) at dose ratio 1:1
(DNA : cross-linker, w:w).
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induced DNA cross-linked proteins in a mammalian cell system and in two target
DNA systems, pBR322 plasmid DNA (supercoiled or circular double-stranded
DNA) and Bst Ell-digested A.-phage DNA (linear double-stranded DNA).
Similar to the formation of DNA-DNA cross-links, structural differences in
the macrocyclic diester substituents of pyrrolic PAs apparently influence the
formation of DNA-protein cross-links. For example, the most potent cross-linkers
such as dehydrosenecionine, dehydroseneciphylline, and dehydroriddelliine all
possess a ,(3-unsaturation in their 12-carbon macrocyclic diester moieties.
Dehydromonocrotaline, which was less potent, contains an 11-atom saturated
macrocyclic diester. Dehydroretronecine, a weak DNA cross-linker, has no
diester substituents. Thus, the major structural features of pyrrolic metabolites
wh ich apparently influence the ability to form cross-links are the presence of
both an a ,(3-unsaturated diester and a macrocyclic diester ring . The number of
atoms in the macrocycle also appears to be an important factor of the DNA
cross-links. These structural attributes also affect the DNA cross-linking potency
and cytopathologic effect of the parent PAs (24, 25) and the ability to induce
unscheduled DNA repair in hepatocytes (9).
In this study, chemically activated pyrroles induced a smaller proportion
(50%) of DNA-protein cross-links than in a previous study from our laboratory in
which PAs were metabolically activated (over 80%) (24). PAs are activated by
the cytochrome P-450 mixed-function oxidase to form pyrrolic metabolites, which
are highly toxic, and N-oxides, which are less toxic. The bioactivation of PAs
appears to be related to an unsaturated C-1,2 bond in the necine base and the
type of necic acid esters (2, 7, 44). That dehydrosenecionine induced more
potent DNA cross-links than that of dehydromonocrotaline in this study affirmed
the previous hypothesis that the type of side groups and number of atoms in the
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macrocyclic diester pyrroles influenced their DNA cross-linking potency.
Moreover, the potency of the chemically activated monocrotaline pyrrole,
dehydromonocrotaline, was similar to that of the macrocyclic u,J3-unsaturated
diester pyrroles such as dehydrosenecionine, dehydroseneciphylline, and
dehydroriddelliine, perhaps because larger proportions of other metabolites of
monocrotaline such as the N-oxide form might be formed than the pyrrolic form
by the cytochrome P-450 mixed-functionoxidase. The relative toxicity of various
PAs in different animal species is also correlated to proportions of toxic
metabolites (2, 6, 44-49).
Using SDS-PAGE and 2-D gel electrophoresis, I found that metabolically
activated PAs or pyrrolic PAs cross-linked DNA with proteins in the 40 - 60 kD
range and that these proteins had a net acidic charge. Because actin (molecular
weight 45 kD), which is associated with gene regulation (50-52), is often crosslinked to DNA in cisplatin or chromate-treated CHO cells, as are other proteins
in the molecular weight around 53 kD and 50 kD with isoelectric points of pi 5.4 9.0 (20), it is possible that one of the DNA cross-linked proteins might be actin.
The necine base (retronecine, dehydroretronecine) and indicine N-oxideinduced DNA cross-linked proteins were not detected. The results affirmed that
DNA-protein cross-links may be a critical factor in PA-induced bioactivity (5, 27),
and also suggested that the majority of DNA-protein cross-links are formed by
pyrrolic metabolites.
DNA cross-linked proteins in the molecular weights of 39 - 68 kD have
been also identified in cis- or trans-dichlorodiammine platinum(ll) or chromium
compound-treated cells (19, 20). The proteins cross-linked with DNA were
identified as nuclear matrix proteins (53, 54). In this study, two standard
bifunctional cross-linkers, cis-dichlorodiammine platinum(ll) and mitomycin C,
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cross-linked proteins in range of 35 - 100 kD. Because activated mitomycin C
has a molecular geometry similar to that of the macrocyclic pyrrolic PAs (55-57),
PA-induced DNA cross-links may be similar to these induced by this standard
cross-linker.
DNA-protein cross-links are thought to be involved in carcinogenic or anticarcinogenic activity of many bifunctional alkylating agents such as nitrogen
mustard and cisplatin (34, 58). Cis-platinum and trivalent chromium cross-link to
the N7 position of guanine (59, 60) and probably bind to cysteine (61 ). In this
study, the interaction of pyrrolic PA and its cross-linking ability in vitro were also
investigated

using

several

proteins.

Dehydrosenecionine

and

cis-

dichlorodiammine platinum(ll) induced DNA cross-links with BSA, which has a
high proportion of cysteine (62). However, these compounds did not appear to
form DNA cross-links with actin or myocin, each of which has a lower proportion
of cysteine than BSA. Possibly I might not be able to detect these cross-links in
my system. Thus, pyrrolic PA-induced DNA-protein cross-links in vitro appeared
to be influenced by the amino acid composition of the protein. Histone was
completely bound with target DNA in this study, which was probably due to the
inherent affinity of this protein to DNA.
The

DNA-BSA cross-linking also occurs following

treatment with

chromium in vitro (63, 64). Lin eta/. (65) investigated metal-induced DNA crosslinks to histidine and cysteine in CHO cells and Salnikow eta/. (66) reported that
more DNA complexes formed with tyrosine and cysteine in chromium-treated
cells, and that histidine, methionine, or threonine were more susceptible than
any other amino acid in vitro.
In summary, DNA-protein cross-linking is likely an important event in PAassociated toxicity, carcinogenicity, and anti-carcinogenicity. Because the major
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molecular weights of PA-induced DNA cross-linked proteins were similar to
those induced anti-cancer agents. the characteristics of PA-induced DNA-protein
cross-links might be similar. The

a . ~-unsaturation

of the macrocyclic ring of

pyrrolic PAs is a structural feature that appears to be important in PA-induced
DNA-protein cross-links. Determination of the amino acid{s) involved in PAinduced DNA-protein cross-links is the subject of studies currently under way.
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CHAPTERV
SUMMARY

Pyrrolizidine alkaloids (PAs) are natural toxins found in a wide variety of
plant species that pose significant health hazards to humans and other animals.
Many PAs are toxic and carcinogenic in vivo or in vitro. Pyrrolizidine alkaloids
are bio-activated by the cytochrome P-450 mixed-function oxidase to form two
major types of metabolites: the bifunctional electrophilic pyrroles that are highly
reactive and can alkylate cellular macromolecules such as DNA and protein, and
N-oxides that are least toxic. Pyrrolizidine alkaloid-induced potent DNA crosslinking activity and the structural features of PAs that influenced DNA cross-links
were examined in our laboratory. However, whether such cross-links are
important to the toxic action of PAs is not clear.
Thus, I examined some of the molecular mechanisms that may affect the
ability of four major groups of PAs and their metabolites to induce cytopathologic
effects and DNA cross-links. I conducted three studies concerning the PAinduced DNA cross-l inks on (1) colony formation and cytopathologic changes,
(2) DNA-DNA cross-links including interstrand cross-links and the cross-linking
site specificity, and (3) DNA-protein cross-links in cellular and target DNA
systems.
In the first study, the ability of eight PA congeners to inhibit mitosis and to
induce megalocyte formation in cultured bovine kidney epithelial (MDBK) cells
was related to their structural features. The macrocyclic a,f3-unsaturated diester
PAs

(seneciphylline, senecionine, riddelliine,

retrorsine)

inhibited

colony

formation and induced megalocytosis in a dose-dependent manner. Colony
growth resumed 3 weeks after these PAs were removed, and cell morphology
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reverted to normal 5 or 6 weeks after these PAs were removed. At high
concentrations (500

~-tM) ,

the a,[3-saturated macrocyclic (monocrotaline) and

open diesters (heliosupine) only slightly inhibited colony formation and did not
affect cell morphology. The necine base (retronecine) did not affect either colony
formation

or

cell

morphology.

The

pyrrolic

metabolites

such

as

dehydrosenecionine, dehydromonocrotaline, and dehydroretronecine inhibited
colony formation more than their parent compounds at 500

~-tM

and were potent

inducers of abnormal cell morphology. An N-oxide metabolite, indicine-N-oxide,
was completely inactive as expected. The results clearly indicated that the
structure of PAs influenced their cytopathologic effects.
In the next study, the DNA cross-linking activities of pyrrolic metabolites
were compared to those of their parent PAs investigated in the cell system.
Pyrrolic metabolites were more potent inducers of DNA cross-l inks than were
their parent compounds. The most potent compounds were the macrocyclic a,[3unsaturated

diester

pyrroles

such

as

dehydromonocrotaline, dehydroseneciphylline, and

dehydrosenecionine,
dehydroriddelliine, which

induced both DNA-protein and DNA-DNA cross-links. The necine base pyrrole
dehydroretronecine and the N-oxide metabolite indicine N-oxide induced
relatively few DNA cross-links. lndicine N-oxide was about as potent as indicine.
Thus, PA-induced DNA cross-linking activity was highly correlated with structural
features and the metabolic pathways of PAs. For example, monocrotaline, which
had little effect on either mitosis and megalocytosis or on the formation of crosslinks, is metabolized by cytochrome P-450 mixed-function oxidase system to a
relatively high proportion of N-oxide.
The comparative potency of a variety of PAs to induce DNA-DNA crosslinks in Bst Ell-digested A.-phage DNA and Bam HI-digested pBR322 plasmid
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DNA was also studied. As in t:he cell system, the macrocyclic
diester pyrroles such

as

dlehydrosenecionine,

a , ~-unsaturated

dehydroseneciphylline, or

dehydroriddelliine induced sign ificantly potent DNA-DNA cross-l inks in Bst Elldigested A.-phage DNA and pB R322 plasmid DNA, and the potency of DNA
cross-links increased in a dose-dependent manner. The macrocyclic

a..~

saturated diester pyrrole such, as dehydromonocrotaline also induced potent
DNA-DNA

cross-l inks.

However,

the

necine

base

pyrrole

such

as

dehydroretronecine, and the N-oxide form of metabolites such as indicine Noxide induce no DNA-DNA cross-links.
In pBR322 plasmid DNA , the macrocyclic

a.,~-unsaturated

diester pyrrole

such as dehydrosenecionine was also the most potent in inhibiting the PCR
amplification of a 1.129kb region of p8R322. The rnacrocyclic

a. , ~-saturated

diester pyrrole such as dehydromonocrotaline was slightly less potent than was
dehydrosenecionine. The necine base pyrrole, dehydroretronecine, and indicine
N-oxide did not induce any interstrand DNA cross-l i nks. The results clearly
indicated

that

the

macrocyclic

a.,~-unsaturated

diester

pyrrole

(dehydrosenecionine) was the most potent inducer of DNA-DNA interstrand
cross-links, and also the structure of PAs influenced thoeir DNA-DNA interstrand
cross-links.
I also determined which nucleotide sequences were likely to be involved
in cross-linking in pyrrole-treated p8R322 plasmid DNA with restriction
endonucleases. In DNA treated with dehydrosenecion1ine, which is one of the
macrocyclic

a., ~-unsaturated

diester pyrroles, the recog1nition site of Ava II, Fok

I, and Taq I was mostly cross-linked, the recognition si1te of Eco Rll and Mbo II
was moderately cross-linked, and the recognition site of Hinf I was least crosslinked. pBR322 plasmid DNA treated with cis-dichlorodiammine platinum(ll)
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completely blocked the action of these restriction endonucleases. There was
only a mild blocking effect in the macrocyclic a ,~-saturated diester pyrrole,
dehydromonocrotaline-treated DNA with Mbo II. In DNA treated with the necine
base pyrrole, dehydroretronecine, or indicine N-oxide, there was no inhibition of
these restriction endonucleases. From the differential inhibition of restriction
endonucleases, there appeared to be no discernible rules regarding sequence
specificity, but the most favorable cross-linking sites for PAs appeared to be 5'd(GG) or 5'-d(GA) sequences, although other sequences such as 5'-d(CG) or 5'd(CC) may be involved.
The nature of DNA-protein interactions induced by PAs was also
investigated because the large portion of PA-induced cross-links was protein
associated in our previous study. The cellular DNA-protein cross-linking activity
of

the

pyrrolic

metabolites

dehydromonocrotaline

>

was

as

follows:

dehydroseneciphylline

>

dehydrosenecionine

>

dehydroriddelliine

>

dehydroretronecine and those that were protein-associated accounted for
approximately

50%

of

the

total

cellular

DNA

cross-links.

However,

dehydroretronecine induced few DNA-protein cross-! nKs, and none were
detected following treatment with indici ne N-oxide. Thus, th e macrocyclic diester
pyrroles were potent cellular DNA-protein cross-links.
Because a major portion of PA-induced cellular DNA cross-links involved
proteins, we characterized DNA cross-linked proteins in cell cultures by isolating
and separating the cross-linked proteins using SDS-PAGE and 2-D gel
electrophoresis. In cells treated with the macrocyclic a~ -unsa tu rated diesters
(senecionine, seneciphylline, riddelliine, retrorsine) , thJe macrocyclic a , ~
saturated diester (monocrotaline) and open diester (helios1upine;, the molecular
weight of the proteins cross-linked with DNA ranged 'rom 40 - 60 kD. The
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chemically activated

pyrroles (dehydrosenecionine, dehydroseneciphylline,

dehydroretrorsine, dehydromonocrotaline) also induced a high degree of DNA
cross-linked proteins in nuclei , but dehydroretronecine or indicine N-oxide did
not induce DNA cross-linked proteins. Nonhistone nuclear proteins were
possibly involved the PA-induced DNA-protein cross-links, and the proteins
induced by macrocyclic diester pyrrole were also detected on the acidic site of 2D gels.

The cross-linked proteins to DNA in patterns were similar to that

induced by the anti-cancer agents, mitomycin C, and cis-dichlorodiammine
platinum (II). These results indicated that the macrocyclic diester PAs or pyrroles
were more potent DNA-protein cross-linkers than the simple necine base.
The pyrrole-induced DNA-protein cross-links were also investigated by
co-incubating actin, BSA, histone, or myosin with dehydrosenecionine in
pBR322 plasmid DNA or Bst Ell-digested A-phage DNA. The DNA-protein crosslinks were formed when dehydrosenecionine was incubated with BSA in pBR322
plasmid DNA and Bst Ell-digested A-phage DNA.
Taken together, these experiments indicated that DNA cross-linking
activity is probably the most critical event leading to PA bio-activity. The
inhibition of colony formation, cytopathologic effects, and DNA cross-linking
activities of PAs are largely due to the action of pyrrolic metabolites rather than
via a common pyrrolic intermediate as was once thought. These results also
cinfirmed that PA-induced DNA cross-links are influenced by three structural
features : the C1 ,2 unsaturation of the pyrrolizidine ring, a,J3-unsaturation, and
the size of the macrocyclic diester ring. Furthermore, because PAs cross-link in
a manner similar to known anti-tumor agents, this work indicates that some PAs
might have anti-carcinogenic activity.
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